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Human Resources for Health (HRH) have been identified as one of the primary
constraints to achieving universal Anti-retroviral Treatment (ART) coverage in South
Africa. This scarcity is exacerbated by the focus on decentralised, primary health care
ART delivery that necessitates a rapid scale up and strengthening of pharmacy
services in terms of supply, infrastructure requirements and HRH to ensure a safe and
efficient pharmaceutical service. The shortage of pharmacists has led to the use of
alternative pharmaceutical care models including indirectly supervised pharmacists
assistants (ISPA) and nurses; however evidence on the costs, benefits and challenges
faced in the implementation of these models are lacking. This study therefore aims to
critically evaluate the ISPA and nurse-based pharmaceutical care models against the
standard of care that involves a pharmacist dispensing ART, on the basis of cost, and
patient preference.
A cost analysis was conducted from the societal perspective and informed by patient
exit interviews (240 respondents), expert interviews, and time and motion studies to
calculate waiting time. The study was set in a peri-urban district of the Western Cape
of South Africa.
While both of the decentralised pharmaceutical care models (ISPA and nurse-driven)
were found to minimise the costs incurred by patients, in travel costs and time, the
nurse-driven pharmaceutical care model was found to be significantly more costly
(per patient visit) from the provider’s perspective than the ISPA model. However,
many patients had a preference for nurse dispensing, generally linked to stigma
concerns when collecting medicines in the pharmacy.
The study highlights the importance of considering the cost of task-shifting on nurses
and the inherent value of their time. Patient preferences and challenges in the
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Index of key terms
Dispensing related activities is defined, for the purposes of this analysis, as activities
relating to stock control, administrative tasks (incl. collecting medication from a
central dispensing unit where applicable), the interpretation and evaluation of the
prescription, the preparation and labelling of the prescribed medicine as well as
counselling of the patient on the safe and effective use of the medication (adapted
from the Pharmacy Act).
Pharmacists Assistant (PA): While there are different levels of PAs employed by the
Department of Health, dependent on their level of completed in-service training,
where the term is used in this dissertation we are referring to PAs who are fully
qualified as Post-basic PAs and are therefore under the Pharmacy Act, able to work
under indirect supervision. The training of a PA from Learner Basic PA to Post-basic












Part A: Research protocol
1. INTRODUCTION
Due to the worsening scarcity of health care workers in Sub-Saharan Africa there has
been an increased focus on task-shifting of the duties of doctors and nurses, but there
is a lack of research on similar strategies to address the shortage of pharmacists.
Task-shifting is not a novel concept in resource-poor settings but has organically
developed out of necessity. It relates to the allocation of tasks in health service
delivery to the least costly health worker capable of doing that task reliably (McPake
and Mensah 2008).  In South Africa, the urgency of care needed in the context of the
HIV epidemic has resulted in a lack of standardised pharmaceutical service staffing
norms but rather different approaches have been adopted at individual ART sites in
line with the available resources. Some clinics have pharmacists dispensing ART.
Another option has been where pharmacists prepare medication from a prescription
for a specific patient at a central dispensing unit or hospital pharmacy from where it is
distributed to the ART clinics and the medication is issued by nurses or counsellors. A
third option currently being piloted in districts in the Western Cape has a Pharmacists
Assistant (PA), working under the indirect supervision of a pharmacist, dispensing
ART as well as managing the drug supply of the clinic (Heli Moeng, personal
communication). These approaches will be referred to as Pharmacist, Indirectly
Supervised Pharmacists Assistant (ISPA), and Nurse-led pharmaceutical care models
respectively.
Pharmaceutical service provision is key to a successful ART service and a limiting
factor if the scale-up of services is to include Primary Health Care (PHC) facilities.
Van Damme et al. (2008) in their article on how the South African health system can
adapt to the need for scaling-up ART, name three constraints to meaningful scale-up:
the ever increasing case load of people who will need long-term ART, shortage and
skewed distribution of Human Resources for Health (HRH) towards the private health
sector, and thirdly the heavy workload inherent in the current ART service provision











no fundamental health system changes and ART gets priority status and a greater
proportion of (already scarce) resources thereby crowding out other services, or the
ART scale-up strengthens the overall health system by stimulating a reform of the
health system towards greater efficiency (Van Damme, Kober et al. 2008). It is
therefore evident that there is a need for implementing less resource intensive models
of ART service delivery while strengthening the health system. Task-shifting and
integrating primary health care and ART service delivery is an attractive solution, but
evidence on this approach is lacking.
1.1. PROBLEM STATEMENT
If South Africa is going to achieve universal access to ART, alternative
pharmaceutical staffing models will be required to address the HRH scarcity which is
limiting the scale-up of ART and therefore people’s access to the healthcare that they
need. Research is required to explore the impact of task-shifting models used.
1.2. JUSTIFICATION OF THE STUDY
Transportation costs and therefore geographical availability has been identified as a
key barrier in access to Antiretroviral Treatment (ART) in Sub-Saharan African
countries (Tuller, Bangsberg et al. 2009). Likewise there is a relationship between
barriers in access to treatment and a lack of sustained adherence to ART (Melese,
Alemayehu et al. 2004; Hardon, Davey et al. 2006; Uzochukwu, Onwujekwe et al.
2009). Adherence to ART is crucial for viral suppression, delaying resistance to
treatment regimens and therefore favourable outcomes. It has furthermore been found
that high ART adherence was associated with lower mean direct health care costs
over time as poor adherence promotes resistance to first line regimens leading to
earlier switching to costly second line ART (Leisegang, Cleary et al. 2009; Nachega,
Leisegang et al. 2010). Improving adherence by increasing availability of ART is
therefore a priority with limited health resources and an increasing burden of need. A
lack of HRH is constraining efforts to expand or roll-out the provision of ART to
lower levels of health care service, which would greatly improve physical availability.











and nurses to improve the geographical availability of ART, there is a need for similar
research and policy recommendations for pharmaceutical services.
1.3. AIMS AND OBJECTIVES
The aim of the study is to evaluate the annual cost per patient treated associated with
two task-shifting pharmaceutical care models, ISPA and nurse driven, against the
standard of care which involves dispensing by a pharmacist. Patient preferences for
different pharmaceutical care models will also be evaluated.
The objectives of the study are to:
 compare the annual cost per patient treated of the task-shifting pharmaceutical
care models (ISPA and Nurse) with the reference (Pharmacist) model;
 evaluate the impact of the different pharmaceutical care models on access to ART
using an access evaluation framework;
 estimate the initial start-up costs associated with the implementation of the ISPA
model;
 formulate policy recommendations based on the findings.
2. LITERATURE SUMMARY
There are many demand and supply side factors which influence individuals’ ability
to access health services (Ensor and Cooper 2004). Access to health services refers to
the “degree of fit” between health systems or health programmes and the individuals
or households that constitutes a society. More specifically, it relates to an individual’s
ability to derive benefits from health care services, and not simply a health system’s
capacity to fund and provide services (McIntyre, Thiede et al. 2009). This definition
of access therefore implies that there are more factors than simply utilisation to
consider when evaluating health programmes (Thiede, Akweongo et al. 2007). These
factors can be evaluated in three dimensions, including acceptability, affordability and
availability. Acceptability relates to the “degree of fit” between provider and patient
attitudes towards and expectations of one another. Patient attitudes towards provider











ability to receive care (McIntyre, Thiede et al. 2009). Cultural practices, beliefs and
preferences also influence acceptability and are a much-neglected aspect of policy and
intervention formulation. Even though ART is currently provided free of charge in
South Africa, it is widely recognised that accessing treatment comes at a cost to
patients (McIntyre, Thiede et al. 2006).  Patients incur economic costs in the form of
the cost of transport to and from the facility, resources spent on additional medical
treatments and home care, as well as opportunity costs in time spent at the facility
(McIntyre, Thiede et al. 2009). Research conducted in South Africa has suggested that
non-drug costs incurred by patients may act as a barrier to patients in accessing
treatment (Rosen, Ketlhapile et al. 2007). This has been supported by research from
South-western Uganda (Tuller, Bangsberg et al. 2009). The final dimension of the
access framework, availability, relates to the staff mix as well as their scope of
practice, the range of services offered relative to the needs of the community. The
location of health care facilities and health services relative to the location of those
who need the services and their transportation opportunities impact on individuals’
ability to access treatment (Ensor and Cooper 2004; McIntyre, Thiede et al. 2009;
Tuller, Bangsberg et al. 2009). This is seen in South Africa where the ART
programme was designed to be pro-equity with respect to the urban and rural parts of
the country and sites were deliberately established in all districts and sub-districts of
the country. However the ART roll-out was initially centralised to hospital services in
these districts, which seriously disadvantaged rural areas. 1This led to a barrier in
access to treatment for those who had to travel far to receive treatment. Cross cutting
factors such as knowledge, power relations, training and professionalism issues
impacts on the expectations of providers in relation to patients and vice versa and
affects all dimensions of access (Goudge, Gilson et al. 2009; McIntyre, Thiede et al.
2009). These dimensions provide a framework within which access can be evaluated.
These dimensions of access and the associated factors impacting on these dimensions
are important to consider in the scaling-up of ART services. The integration of ART
into primary health care services, as opposed to a specialised hospital-based service,
has been proposed. It could be argued that providing ART closer to communities
1 Many thanks to Prof. Helen Schneider for pointing out the difference between the rural-urban bias versus barriers to access due











would improve the ability of those in need to access treatment. Evidence from a
Medicines Sans Frontiers (MSF) clinic in Lusikisiki, South Africa has shown that
decentralised HIV/AIDS care, due to greater proximity and acceptability of services,
has led to faster enrolment and better retention compared to a centralised hospital
based approach (Bedelu, Ford et al. 2007).  However, providing ART at primary
health care clinic level would require a scale-up of services and resources while
straining an already over-burdened health service and if not addressed could result in
the crowding out of patients with other needs. The current model for the provision of
ART is very resource intensive and does not lend itself to universal access to
treatment as ART services are provided in the form of a vertical program with
pharmacists, doctors, nurses and administration dedicated exclusively to ART
provision. This approach has elements of inefficiency as factors such as economies of
scale, economies based on learning by doing and economies of scope influences the
amount of resources (including HRH) required for the provision of ART (Cleary,
Boulle et al. 2008).
In South Africa there has been a move towards a nurse-based, doctor-supported ART
service to be integrated into the district health system (Provincial Government of the
Western Cape 2007). Task shifting could be a possible solution for reducing the cost
of health care and optimising human resources as it involves the delegation of certain
activities to less qualified, specifically trained, health care personnel. Examples of the
use of lay workers in South Africa include the community health worker and
community-based volunteers for giving directly observed treatment for tuberculosis
during home visits (Philips, Zachariah et al. 2008). In a multi-country study Huicho et
al. (2008) found that in underserved rural areas where health care needs are the
greatest, health workers with longer pre-service training (i.e. doctors) are less
available than those with shorter pre-service training (i.e. nurses). Furthermore, a
study performed in Mozambique found that there was less migration by mid-level
workers trained in the country than physicians. They found that 90% of mid-level
workers recruited from rural areas, returned and stayed in rural areas for a minimum
of seven years after graduation compared to 0% of physicians. This is thought to be











training is based on European standards (Kruk, Pereira et al. 2007). Task-shifting
could therefore assist in the retention of skills where they are most needed.
Critics of the concept of task-shifting have urged caution and more operational
research in order to ensure that quality of care for patients on ART is not
compromised, amid growing concern around adherence and detection of treatment
failure (Philips, Zachariah et al. 2008). Inferior quality of care is often mentioned as
an argument against task-shifting. Research has however found evidence to the
contrary. A comprehensive multi-country study by Huicho et al. (2008) comparing the
performance of different categories of health workers trained in the Integrated
Management of Childhood Illness (IMCI) and child mortality has fuelled the task
shifting debate. Huicho et al. found that the quality of care (defined as compliance
with IMCI guidelines for assessment and treatment of sick children) did not differ
between those with longer and shorter duration of pre-service training. The IMCI
treatment was delivered in primary health care facilities. One of the explanations
offered is that health workers with shorter duration of training might be more willing
to comply with standard clinical guidelines than health workers with more training
who might be accustomed to taking short cuts or delegating some tasks such as
counselling to clerks dispensing medication at the end-point of service delivery
(Huicho, Scherpbier et al. 2008).
There has also been resistance to task shifting from professional bodies, which are
seen as promoting narrow economic interests of specific professional groups. In
Brazil, pressure from professional bodies led to the discontinuation of IMCI training
for nurses in 2002 (Huicho, Scherpbier et al. 2008). In Uganda, the Professional
Council of Pharmacists opposed the introduction of training for pharmacy assistants.
The Nurses Council furthermore opposed the accelerated training of nurse assistants
(McPake and Mensah 2008). Conversely, in Ghana, Malawi, Tanzania, and Zambia
nurses were trained and allowed to perform tasks traditionally restricted to physicians,
providing support for task shifting practices long before the practice was accepted











South Africa has policies and regulations in place that could enable the task-shifting
of pharmaceutical services to professional nurses or PAs where pharmaceutical
services are lacking in order to ensure access to essential care. The National Service
Plan (NSP 2007 to 2011) provides guidelines and targets for a comprehensive
response plan to the HIV epidemic. Targets include that 80% of new patients should
be initiated and managed by nurses, and that 70% of people on ART would be
managed outside of the hospital setting by 2011. The NSP further acknowledges that
the development and implementation of new innovative staffing norms that are
sustainable and have the potential for growth in order to scale-up ART is required.
National treatment protocols for HIV as well as the scheduling of ART medication as
Schedule four substances enable nurses to safely dispense ART. Section 33 of the
Nursing Act allows for professional nurses to dispense medication if in possession of
a dispensing license. Section 56 (6) of the act provides for the Director General, head
of the Provincial DOH or the doctor in charge of a municipality to authorise nurses in
service of the DOH, or municipality to assess, diagnose and treat patients where no
doctor or pharmaceutical service is available, but this applies only for medication up
to Schedule four. The National Drug Policy of 1996 states that prescribing should be
competency not occupation based, and that doctors and nurses should dispense where
no pharmaceutical service is available, provided that the health professional has a
dispensing license from the Medicines Control Council.
It can therefore be seen that there is a great deal of policy and legislative provision for
dispensing by clinicians where pharmaceutical services are not available. This enables
nurses to provide a complete service of managing and dispensing ART in a PHC
setting. These practices would however take time away from the clinical duties of the
health professional and could restrict scale-up of services (Schulman, Makani et al.
2009). In light of the severe shortage of nurses in South Africa, this may not be a
viable solution. The South African Pharmacy Council allows for the registration of
PAs, a category of mid-level worker who are trained and employed in pharmacies to
perform administrative or repetitive tasks essential in the operation of a pharmacy











The Pharmacy Act 53 of 1974 deals with the scope of practice, training as well as
registration of PAs. It also allows for PAs working under the indirect supervision of a
pharmacist in government facilities. Regulations GN1158 and GG21754 of the Act
(20 November 2000) specifies that a PA working under indirect supervision must be
visited once a month by the designated supervisory pharmacist and that such visits
should be documented (Honermann 2009). An enabling regulatory framework for the
task-shifting of pharmaceutical services is therefore available in South Africa but




A more detailed literature review will be conducted, exploring the issues around
access to health care, HRH concerns, and task shifting. Electronic databases such as
PubMed, EBSCOhost, South African National Health Research Database, Google
Scholar and grey literature will be used.
3.2. STUDY DESIGN
A cost analysis will be conducted from a modified societal perspective and the impact
on patients will be critically evaluated using the access evaluation framework.
3.3. STUDY POPULATION AND SAMPLING
Data collection will take place within the Cape Winelands district of the Western
Cape, in the Stellenbosch and Drakenstein (Paarl) subdistricts. Within the subdistricts,
facilities providing ART services will be stratified on the basis of the pharmaceutical












Group A Facilities where pharmacists are dispensing ART medication directly to
patients.
Group B Facilities where PAs work under the indirect supervision of a
pharmacist and dispense ART medication directly to the patients (pilot
sites).
Group C Facilities where patient-ready packs are dispensed by pharmacists at a
central facility (e.g. district level hospital or central dispensing unit) and
then transported to the ART clinic where the medication is issued by
nurses.
Within the strata, purposive sampling has been used to select facilities based on the
advice of the NGO partner’s project manager in Paarl (Dr Nelis Grobbelaar, personal
communication). This sampling strategy is used partly due to the limited extent to
which these services are available and in order to ensure that samples are
geographically representative. Six facilities will be sampled with two facilities from
each stratum. Idas Valley clinic and TC Newman CDC will provide information on
the pharmacist pharmaceutical care model, Mbekweni and Kyamandi CDCs will
represent facilities where indirectly supervised PAs are dispensing, and Dalvale  and
Franschoek clinics will provide the sample for nurse-driven pharmaceutical models.
Equal numbers of patients will be selected from each stratum in order to have a
sufficient sample to inform the costing component of the study. Within the strata
(groups), the number of individuals to be selected from each facility has been
calculated to be proportional to the size of the facility in the strata (proportional
stratified sampling).
Table 1
Participant inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Persons older than 18 years. Persons younger than 18 years











3.4. SAMPLE SIZE CALCULATION
Patient exit interviews will be conducted, the results of which will be used to inform
the costing. In addition differences in access to ART between the specified groups
will be explored. In order to make statistically significant inferences regarding these
differences, the sample size required were calculated using a one-way ANOVA power
analysis.
An estimate of the anticipated outputs in the groups is required when calculating the
appropriate sample size. The anticipated outputs of interest were identified as patient
travelling and waiting times, used in the cost analysis to estimate indirect patient
costs. Data from a recent study, Researching Equity in Access to Health care
(REACH) was used to estimate the output with the smallest mean, therefore requiring
the largest sample size to detect differences. One could therefore assume that if the
sample size calculated is large enough to show statistically significant differences in
the most sensitive outcome it would be adequate to show differences in other outputs
measured. A one-way ANOVA power analysis was then conducted using PASS®
software. The power of the test and standard deviation was varied to determine the
optimum combination, considering resource limitations. The power of the test refers
to the probability of rejecting a false hypothesis, which should be close to one (or
100%).  For the test to have a power of 85% and a standard deviation of 80 a
minimum sample size of 105 respondents (66 from Group A, 18 from Group B, and
21 from Group C) are required. In order to provide adequate information for the
costing, equal numbers of interviews will be conducted from each group of patients.
Therefore 70 interviews will be conducted within each group, with a total sample of












































The ART clinics use an appointment system for patients to collect their medication;
however patients do not arrive at a predetermined time, which makes random
sampling from the appointment book impractical, as all selected patients may be
ready to leave at the same time. Therefore systematic sampling will be used to select
the patients to be interviewed. A list of patients at each clinic will be obtained; the
total number of patients on ART at each clinic will then be divided by the target
sample size for the clinic. The output will represent the interval of sampling. The first
patient to be interviewed will be selected at random and each clinic will be sampled
on multiple days. This would limit the introduction of biases related to respondents
who have systematic differences in for example employment accessing the clinic at
different times of the day as well as different days of the week.
3.5. MEASUREMENT TOOLS
A range of collection tools will be used to inform the cost analysis and are












Data collection tools and sources

























Costs of staff time
Costs of patient’s time
70
Interviews with
clinicians and timing of
tasks (clinical staff,
facility observation)
Portion of time spent
on dispensing related
duties.








Cost per patient treated.
Resource use Not applicable
3.5.1. Facility Observation
Patient waiting time and the amount of time clinical staff spend on dispensing related
duties will be determined by observation within the facilities. To determine patient
time, each patient attending the clinic on a given day will be supplied with the
designed observation tool upon entering the facility. The time of entry of the facility,
time in and out of nurse’s rooms, time in and out of doctor’s rooms, time of arrival at
dispensary and time of exit of facility will be recorded (see Appendices). The amount
of time clinical staff spends on dispensing duties/ medication management duties will
be determined by interviewing clinical staff. In order to validate their responses, the











3.5.2. Patient Exit Interviews
Exit interviews will be conducted with patients selected in line with the inclusion
criteria (see Table 1). The interview guide is attached in the appendices (see Appendix
3). Fieldworkers will administer the interview guide in English, Afrikaans or Xhosa as
appropriate, and the patients’ responses will be recorded on a paper-based interview
guide form. The interview guide has been designed to elicit responses that can be used
in calculating the costs related to accessing ART, for patients receiving care from
facilities using different methods of dispensing and managing ART drugs. It includes
questions on demographic information, frequency of ART service utilisation, direct
and indirect costs incurred during service utilisation, transport to the facility,
affordability of accessing treatment, and patient preferences.
3.6. PILOT STUDY
The interview guide and observation tool will be piloted to ensure that questions are
easily understandable and aimed at the correct level. Furthermore, piloting will help to
determine the nature of potential responses, difficulties in the administration of the
interview guide and observation tool as well as to estimate the ease with which
potential respondents will be recruited relating to the potential for achieving the
required sample size. It will also be useful to determine the approximate time taken to
conduct an interview. The interview guide will be piloted on 10 patients who comply
with the inclusion criteria for sampling. They will be interviewed using the interview
guide. Following the interview, respondents will be asked about the clarity of the
questions, and their understanding and comprehension of the questions. The pilot
study will be conducted in the same population to be studied but not selected into the
sample and responses will not be included in the analysis.
3.7. FIELD MANAGEMENT
Prior to commencement of fieldwork, fieldworkers will be trained and familiarised
with the use of the interview guide. Two fieldworkers (including the principal











facility staff. One of the fieldworkers will manage the collection of time data while
the other conducts interviews, based on the predominant language spoken at the
facility. Fieldworkers will spend a full day at the clinics in order to sample all
required patients attending the ART clinic at different times of the day, as there may
be systematic differences in patients attending the clinic during different times of the
day.  Each patient exit interview will take approximately 15 minutes and an expected
minimum of 8 interviews will be conducted per clinic day. The location where the
interview will be conducted will depend on the individual clinic. This will be
discussed with the facility manager on day one of data collection and a room decided
on that would ensure privacy, and minimal disruptions and inconvenience caused to
the smooth running of the facility and staff members.
3.8. QUALITY CONTROL
Each aspect of the study poses unique problems in maximizing validity and reliability.
The following approaches will be used to maximise validity and reliability:
Improvement of validity
 Fieldworkers will be required to have excellent communication skills, verbal and
literate fluency in English and either Afrikaans or Xhosa. Fieldworkers will be
trained on the terms used in the study, foundations of the subject matter and in the
application of the interview guide.
 Fieldworkers will be encouraged to document any problems or concerns raised
during interviews, and these will be addressed and corrected for during weekly
team meetings and more informal daily report backs to the principal fieldworker.
 Details of interviews, including name of interviewer, time started and time
completed will be recorded on the interview guide and stored, should there be a
need to address quality control concerns.
 The data from interviews will be captured concurrently with data collection, so
that problems can be identified and relayed to the interviewers instantly for
improvements in further data collection.
 Pilot study: the interview guides and observation tool will be piloted on a group of











be analysed but used to correct problems with the interview guide as well as
further training for the fieldworkers. It is an opportunity to correct any problems
related to comprehension, understanding or ambiguity. The wording, timing,
presentation and flow of the interview guide will also be tested during the pilot
study.
 Attempts will be made to correct for potential sources of social desirability bias,
i.e. patients providing responses they believe to be more acceptable and in line
with societal norms. These issues will be kept in mind while conducting the
interviews and as well as during the training of fieldworkers.
 Respondents will furthermore be assured of the privacy of interviews and that
health workers will be not able to access their responses.
 Researchers will measure patient time spent waiting in the facilities for treatment
rather than relying on respondents’ estimates.
Improvement of reliability
 Fieldworkers will be trained on how to administer interview guides and
irregularities will be identified during questionnaire quality control review and
data capturing. Any concerns will be addressed and corrected.
 Double entry of data will also minimise errors introduced during the capturing of
data.
 The quality of completed interviews will be checked daily. Missing values will be
identified and fieldworkers requested to provide feedback. This will improve the












4. LOGISTICS AND TIME SCHEDULE
Figure 1
Proposed time schedule

































Assuming that 8 patient exit interviews will be conducted per clinic day per
fieldworker, and taking into consideration that ART clinics are offered between one
and five days per week, data collection would take approximately six weeks. One
afternoon per week will be reserved for administration, planning and team meetings to
discuss progress.
5. DATA MANAGEMENT AND ANALYSIS
5.1. ACCESS EVALUATION FRAMEWORK
The results of the study will be used to critically assess and evaluate the impact of the















Dimensions AVAILABILITY AFFORDABILITY ACCEPTABILITY
Factors
Geographical availability/


















health and of paying






Root causes Scope of practice
(task-shifting)
Efficiency
Constrained resources Power relations
Source: Adapted from McIntyre, Thiede & Birch (2009)
As discussed previously, access is defined as the “degree of fit” between health
services and the individuals or households that constitute a society (McIntyre, Thiede
et al. 2009). To evaluate the impact that the different pharmaceutical care models
have on access to ART, factors relating to the three dimensions of access (availability,
affordability and acceptability) as well as their root causes will be explored.
5.2. ANALYSIS OF PRIMARY DATA
The interview guide has been pre-coded for ease of data entry (see Appendix C for
coding used for variables). Data will be double-entered using the Epidata®
programme, which allows for the cross-checking of errors during the second-entry to
ensure that data is entered correctly and will greatly reduce errors introduced during
data capturing. A data-capturing guide will also be compiled for data capturers to
ensure that data capturers capture data in a similar fashion. Furthermore, data
capturers will be trained on the use of the Epidata® software as well as the interview
tools. Following data entry, the data will be exported from Epidata into STATA 10®,
cleaned and prepared for analysis. Any strange or missing values will be identified
during data checking and investigated by going back to the raw data. Estimation/












Numerical data will be explored using histograms, the generation of frequency tables
and box plots.  This includes respondent characteristics such as age. Numerical data
will be summarised using measures of central location such as the mean and the
variability of data.
Categorical variables will be explored using frequency tables showing proportions for
each category. These include the age and sex distribution, utilisation of ART services,
adherence to treatment, availability, mode of transport, and acceptability of treatment.
Data will be summarised using pie charts and bar graphs.
5.3. COST ANALYSIS
5.3.1. Costing conceptual framework
A marginal analysis approach will be taken to the costing of alternative dispensing
approaches, whereby only costs that differ will be focused on. Costs that are common
to all three approaches (such as the cost of ARTs) will be excluded (Drummond,
Sculpher et al. 2005). The costs associated with the different dispensing systems will
be sourced from expenditure data, primary data collection, and expert opinions. All
costs (except for the policy brief which is targeted at local managers and policy
makers) will be presented in US Dollars, expressed in 2009/2010 prices and inflation
adjustments will be made using CPIX, the Consumer Price Index.
Perspective
In order to make inferences regarding the impact of the different pharmaceutical care
models on the availability of ART, non-health care costs incurred by those accessing
treatment such as cost of transport and other possible barriers would also need to be
considered. Costing therefore takes a societal perspective in defining costs (Luce,












Unit cost refers to the total economic cost per patient visit, and includes both variable
and fixed costs i.e. costs that do and do not vary with the scale of provision. The
economic definition of cost is based on the concept of “opportunity cost” referring to
the benefits lost because the next-best alternative was not selected and implies that all
resources consumed by an intervention are valued and not only those that could be
represented in a budget (Gold, Siegel et al. 1996; Clewer and Perkins 1998; Johns,
Baltussen et al. 2003).  Costs will be categorised into provider (staff time), direct non-
health care (cost of transport) and indirect (patient-time) costs components.
5.3.2. Provider costs
As the costing takes a societal perspective, costs incurred by the patient, the health
system and other relevant individuals are considered. Cost definitions and allocation
basis to be used is summarised in Table 4.
The primary cost difference from the health service perspective relates to the cost of
HRH. Salary costs will be calculated from gross (pre-tax) salary and contributions to
pension and medical funds plus other benefits will be taken into account. Capital costs
are defined as resources that last for more than a year, and under this definition,
training costs should also be included as capital costs. However, in line with the
methodology used in the WHO-CHOICE project, the current level of education of
health professionals is excluded since a reallocation of health system resources does
not affect these costs (Johns, Baltussen et al. 2003). A proxy for the additional cost
relating to level of education would be the salary of the professional, as salary level in
the public sector is directly related to years of experience and level of education. In
the final analysis, the time required to train the respective professionals will be












Costs and sources of cost data
Recurrent (health system) costs
Allocation basis Description






Percentage of time This will include all staff involved in dispensing
(nurse, PA and/or pharmacist). It will be assessed
through timing staff to determine the percentage






Percentage of time In the PA model, in accordance with the
Pharmacy Act a designated supervisory
pharmacist will supervise the PA under indirect
supervision and scheduled supervisory visits.
Time spent at the facility will be calculated as
percentage of total work time.
Direct non-healthcare costs




Direct Patients’ mode of transport and cost of the




Direct ART is provided free of charge, however at some
facilities (such as hospitals) user fees whether
formal or informal may apply.
Cost of treatment
(patient exit interviews)
Direct These costs refer to costs incurred by patients
when having to purchase medication not provided







Direct These costs include the payment of another person
to perform tasks the patient would ordinarily
perform but is unable to do so as is accessing
treatment at the facility; this would include the
cost of a childminder.
Income loss on the day of
clinic visit
(patient exit interviews)
Direct Income loss would refer to the loss of earnings
from having to forgo work to spend a day at the
clinic.
Since the cost of ART drugs per patient does not vary across programme models,
these costs will be excluded from the analysis. Furthermore, some of the costs of
central administration relating to the overall planning and management of the health
system and not directly related to the health system programmes evaluated will be
excluded (Johns, Baltussen et al. 2003).
Where costs/ expenses are funded by donor funding, these will be specified and
included as at some point these functions will be taken over by a government












A key characteristic of the societal perspective is the inclusion of time costs, the use
of opportunity costs and community preference (Meltzer and Johannesson 1999;
Garrison, Mansley et al. 2010). The inclusion of productivity losses related to the time
spent by patients travelling to and from the clinic as well as waiting time, is very
contentious in the economic evaluation literature (Drummond, Sculpher et al. 2005).
Previous studies on the cost to patients accessing ART in SA has found that most of
the patients were not employed, few (4 – 16%) indicated any loss of income because
of time spent at the facility or reported paying for substitute labour (4 – 13%) while
visiting the clinic, and for those who are employed, SA labour law enables employees
to have access to paid sick leave which would minimise a loss in income (Rosen,
Ketlhapile et al. 2007).  Furthermore, Drummond et al. (2005) point out that during
short-term absences, losses in production could be compensated for by the worker on
their return to work, or by colleagues. Also, for many categories of workers the value
of productivity lost at the margin is likely to be lower than the average wage as all
jobs contain tasks that are less important that are usually forgone as a result of a short
period of absence. However given the lack of paid sick leave in the informal job
market, and in order to include differences in waiting and travelling times between
facility, for the purpose of this analysis, opportunity cost will be reported separately in
the cost analysis, leaving it up to the decision maker as to whether or not to take them
into consideration.
5.3.4. Start-up Costs
Calculating the costs required in upgrading current “medicine rooms” in PHC
facilities to comply with SAPC regulations for dispensing ART will be performed as a
separate costing exercise to avoid double counting of certain categories of costs. The
results will be used to comment on the feasibility of a scale-up of this service at a
PHC level given the resources required. The need for a decentralised ART service in
an effort to provide universal access to treatment is well established. Structural
improvements to PHC facilities to enable accurate dispensing and the safe storage of











Primary Health Care clinic level. However, in terms of this analysis, adequate
dispensing areas are only essential for the ISPA or pharmacist pharmaceutical care
models, as when nurses dispense pre-packed ART medication, designated SAPC
approved pharmacies within PHC facilities are not required as pharmaceutical
services are provided from a hospital or day-hospital. The costs associated with
setting up a dispensary in a PHC clinic to the standards required for registration with
the SAPC are included in this study as these costs could conceivably be a barrier to
the scale-up of an ISPA pharmaceutical care model. Section 22A of the Medicines
and Related Substances Act 101 of 1965 as well as Regulation(s) 1.2 and 1.3 of the
Regulations pertaining to the Pharmacy Act 53 of 1974 specifically relates to the
handling, storage and minimum standards for pharmacy premises, facilities and
equipment (PSSA Pharmacy Law Compendium: PRE 174 – 185).
Expenditure data relating to the start-up cost of setting up a SAPC approved
dispensary in a PHC clinic will be sourced from expenditure reports and suppliers.
5.3.5. Costing Assumptions
Where applicable, it is assumed that a working day has 8 working hours and that a
month has 22 working days.
5.4. UNCERTAINTY
In conducting an economic evaluation, certain costing assumptions are made, which
could have important implications for the decision making process. The analysis is
subject to uncertainty relating to data requirements, the choice of analytic method as
well as the generalisability of the results (Briggs, O'Brien et al. 2002).
The percentage of time and types of staff involved in dispensing related activities will
be determined by observation in the facilities (timing) and the percentage time
allocated will then be varied in order to test the assumption of time spent on












The proposed budget for the study is summarised in Table 5. This study will be
funded by the National Research Fund (NRF) South African Research Chair: Health
and Wealth program.  Unit costs were derived from the UCT planning and budget
guidelines (version 05/10), available from www.uct.ac.za/usr/finance/notices/
budgui10.xls  (Accessed 24 November 2009).
Table 5
Outline of Budget






8 pages R150 per page R1 200 x 2
R2 400






8 pages x 220
1,760 pages
Observation tool:
1 page x 220
220 pages
R0.40 per page R792





R0.45 per label R198







x 20 days = 2,900
km
R2.92 per km R8 468














Stationery Pens and pencils R100
Total R20 458
An interview training guide will be developed and translated into both Xhosa and
Afrikaans, which are the dominant languages spoken in the Western Cape.
Professional translation will only be required for the Xhosa translation, as the
researcher will perform the translation into Afrikaans. Following the initial
translation, the training guide will then be back-translated from Xhosa into English to
ensure the quality and the correct interpretation of the translation. Numerical labels
will be printed to represent the patient number. There will be two labels of each











the patient exit interview guide. Travel costs of the fieldwork co-ordinator were
calculated by averaging the distances to be travelled to and from the respective
facilities per day, and the average distance (measured in kilometres) per day was then
multiplied by an estimated number of days of supervision visits.
7. ETHICS
Potential Benefits
There are no personal benefits to participation in the study; however it could benefit
the community through the future planning and efficient delivery of health care
services. This study will directly benefit the communities in which the research is
conducted as it informs methods of decentralising ART and improving the availability
of treatment.
Potential Harms
While the study does not involve invasive procedures, potential harms to participants
of the patient exit interviews involve the loss of anonymity in the process of
interviewing. These harms are most acute in communities where HIV infection is
stigmatised and people who are HIV positive are reluctant to reveal their status for
fear of discrimination and stigmatisation. Taking care in ensuring confidentiality
during the interviewing of patients will minimise these harms. In each facility
selected, private rooms will be used for conducting patient exit interviews.
Accountability
Permission will be obtained from the relevant health authorities and facility managers
for the interviews and data collection. A patient information sheet will be designed to
provide participants with a background to the study, emphasising their role in the
study, measures employed to protect their confidentiality as well as their right to opt
out of the interview/ survey at any point (see Appendix 1). Signed informed consent
will be collected during the patient exit interviews (see Appendix 2). Consent forms
as well as patient exit interviews will be translated and conducted in any of the three
most prevalent languages spoken in the Western Cape, English, Xhosa and Afrikaans.











stated in the patient information form, which will be given to participants to keep.
This will improve the accountability of the researchers.
Incentives
There will be no monetary compensation for participants of the patient exit
interviews.
8. DISSEMINATION OF FINDINGS
This study will be submitted towards fulfilment of the requirements set for a Masters
in Public Health (MPH), specialising in Health Economics. A journal article and
policy brief will be written on the findings and a research report submitted to the
Western Cape Provincial Department of Health. Findings will be presented at regional
conferences attended by public health sector staff. A summary report will also be
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Part B: Literature review
9. INTRODUCTION AND METHODOLOGY
The objectives of the literature review are to identify studies measuring the costs and
outcomes of pharmaceutical service delivery models, to understand some of the
reasons for the scarcity of Human Resources for Health (HRH) in Sub-Saharan
Africa, the theory and empirical research around task-shifting and the impact on
patients’ access to health care.
Databases used in searching for and identifying research studies included MedLine,
PubMed, Google Scholar, conference abstracts and presentations, as well as the South
African National Health Research database and the Cochrane Library. Resources were
included from published sources and grey literature, opinion or policy reviews,
literature reviews as well as primary research. As studies on health human resources
in developed nations lacked generalisability to the South African setting, there was an
emphasis on research conducted in Low- and Middle- Income Countries (LMIC),
although research from developed countries was not excluded. In addition to the
database searches, a snowball approach was used to identify potential articles from
the reference lists of relevant articles.
10. DRUG SUPPLY MANAGEMENT
Access to essential medicines is often constrained in less developed or impoverished
countries, and the availability of essential medicines is considered to be a proxy for
the quality of care in a country. There are many country and region specific reasons
for a lack of access to essential medicines, but the reasons can broadly be summarised
into the following categories;
 a lack of sustainable funding,
 poor planning and management of drug procurement and distribution processes,











These issues are becoming even more urgent and the battleground for access to
essential medicine now also includes ART due to the high economic costs of
treatment failure (Vogel and Stephens 1989; Quick, Boohene et al. 2005; Harries,
Schouten et al. 2007; Waako, Odoi-adome et al. 2010).
Many studies commenting on problems with drug stock outs or lack of essential
medicines in countries focus on the financing and procurement aspects of drug
supply. However, Windisch and others argue that in reality, many other components
of service delivery, not directly related to supply chain management, may impact on
the availability of medicine such as the adequacy of infrastructure and HRH
(Windisch, Waiswa et al. 2011). External funders supporting ARV services might
attempt to mitigate these conditions by implementing parallel systems of drug
distribution. In Malawi, for example, it was found that a focus on a single first-line
regimen for ART simplified the process of drug ordering, drugs were then packaged
into easy to use “starter packs” and “continuation packs” to assist in distribution at
facility level. In addition drug level “ceilings” were decided on and quarterly data on
patient outcomes were used to calculate future drug needs. In addition, a parallel
procurement agency (i.e outside of government structures) was used where the
government procurement system was weak (Harries, Schouten et al. 2007). While
these initiatives worked initially, it did not strengthen the countries’ drug procurement
and distribution systems and the parallel system started failing as the ART service
grew and new drug regimens were added to the requirements (Schouten, Jahn et al.
2011). The study concluded that a more systemic approach needs to be taken.
One of the needs of a functioning drug procurement and distribution system is
pharmaceutically trained HRH. A survey of HRH found that in Malawi the vast
majority of mission facilities were severely understaffed with as few as 20% having
any pharmaceutically trained staff, and Uganda fared only marginally better at 22%











11. HUMAN RESOURCES FOR HEALTH
Human resources to treat HIV/AIDS is considered to be one of the main constraints to
achieving universal Anti-Retroviral Treatment (ART) coverage (Kober and Van
Damme 2004; Hirschhorn, Oguda et al. 2006; Barnighausen, Bloom et al. 2007; Van
Rensburg, Steyn et al. 2008).  Current ART coverage for LMIC is estimated to be
28% to 32% and according to Barnighausen et al. (2007) will drop to between 16%
and 19% by 2017, if human resources for health (HRH) production rates are kept
constant, considering the inflow of people needing treatment (Barnighausen, Bloom et
al. 2007).
HRH can be broadly defined as “the stock of all individuals engaged in the
promotion, protection or improvement of population health” and, according to the
World Health Organisation (WHO), includes those working in the public and private
sectors, in clinical, research as well as public health interventions (World Health
Organization 2000).  Globally it has been found that there is a close correlation
between the number of qualified health workers and key health outcomes related to
the quality of health care, such as the infant mortality rate, immunization coverage
and maternal survival. This is thought to be because, within a health system, qualified
health workers function as gatekeepers for the efficient or wasteful use of all other
resources such as drugs, vaccines and supplies (World Health Organization 2006).
Given the importance of HRH to a country, it is not surprising that there is a heated
debate on the best method of calculating the need for HRH, which impacts on
planning and capacity building. HRH planning attempts to match the available supply
of trained health workers with the demand for the resources, and is not only a
technical process, but also a political one. Decisions related to the number, types and
distribution of health workers depend on political, and economic choices as well as
the social values that underlie a particular health system and country (Fulop and
Roemer 1987; Birch, O'Brien-Pallas et al. 2003; Dreesch 2005). While there are
several different technical approaches used in estimating HRH needs in a country, a












11.1. INTRODUCTION TO THE HRH PRODUCTION FUNCTION
If one were to consider the need for HRH as a production function (see Fig. 1)
representing the relationship between the quantity of inputs used (human resources)
and the quantity of outputs produced from those inputs (for example, the number of
patients receiving ART), the output produced from a given number of providers can
be said to depend on a number of production factors (O'Brien-Pallas, Birch et al.
2001; Birch, O'Brien-Pallas et al. 2003).
Figure 1: Human Resources for Health (HRH) production function
Provider level production factors include, the quality of training that staff receive,
their level of experience, productivity, morale and attitude towards patients, in this
case people living with HIV/AIDS. These individual provider related production
factors will influence staff’s efficiency and thus ultimately the number of staff that
need to be employed. Productivity, defined as the ability to render a service, is further
impacted by HIV in that health workers can contract HIV themselves and in addition,
absenteeism can be high due to workers needing to attend to family members who are
ill (Hirschhorn, Oguda et al. 2006).
The determinants of service outputs in the HRH production function are not restricted











isolation, but use their skills and knowledge in combination with other human and
non-human resources to provide health services to meet the needs of the population.
Therefore system factors that may influence the extent of the need for HRH include
the range of care offered, staffing models, visit frequency, facility characteristics, the
type of facility or sector, the current facility resources, facility ART experience,
characteristics of the patient population as well as local and national support for the
implementation of HIV/ART programmes (Hirschhorn, Oguda et al. 2006). On a
more global level, the scarcity of HRH as well as the push and pull factors impacting
on the migration of HRH away from developing countries towards more developed
countries also impact on the availability of HRH. These factors in turn influences
national policy towards a shifting or reallocation of tasks (task-shifting) towards less
internationally mobile health workers (these concepts are discussed in more detail in
chapters 10.2 and 10.3). At a local level, the frequency and intensity of patient visits
is dictated by the severity of the patient’s condition, maturity of the programme,
national guidelines and intensity of the management of adherence and side effects,
which influence the demand for health care and therefore HRH. The more
experienced staff are in HIV management, the more productive they will be and the
lower the staff requirement is (Cleary 2010). At a new site, the number of patients on
ART will tend to increase slowly as staff and site experience increases and patients
are initiating treatment but after some time, more and more patients will be coming
for follow-up treatment and therefore the patients in care will grow rapidly for a
period of time even without additional staff. However, as the site nears full capacity,
more patients will experience treatment failure or toxicities and the site’s ability to
manage patients and enrol new patients will decrease unless additional resources are
added (Hirschhorn, Oguda et al. 2006).
In theory, we would want the combination of inputs that minimises the cost of
producing the required services while maximising the outputs. However, the
availability of certain inputs (such as HRH) may constrain the range and type of












In 2006 the World Health Report concluded that “in many countries the skills of
limited yet experienced professionals are not well matched to the local profile of
health needs” (World Health Organization 2006). Where the skills mix is not matched
to local need, health care services become less available, and where available they
become less affordable (Fulton, Scheffler et al. 2011).
If we consider the production function from a different perspective (see Figure 2), we
see that the optimal staff mix would be the combination of HRH provided at a
particular quality for the lowest cost, and this is considered productively efficient. The
number and mix of staff required can be depicted in a production function graph,
represented in Figure 2 below.
Figure 2: Graphical representation of the Human Resources for Health (HRH) production function
Source: Fulton et al. (2011)
Figure 2 represents the nurse to physician staff mix in a particular health service. The
horizontal axis represents the number of physicians and the vertical axis represents the
number of nurses. The straight line that intersects the axes represents a fixed budget
constraint along which total staffing costs are equal. Where the budget constraint line
intersects the horizontal axis, the entire budget is used for physicians and where it
intersects the vertical axis, the entire budget is used for nurses. The curve Q2





















nurses, while Q1 represents a different quantity that is greater than Q2. The figure
shows a productively inefficient skills mix (point A) and a productively efficient skill
mix (point B). Point A is not productively efficient as the service provider could
decrease the number of physicians from PA to PB and increase the number of nurses
from NA to NB – this change would not increase costs but would produce a greater
quantity of health service (Q1 > Q2). The productively efficient point is where the
quantity of services at a given quality is maximised subject to the available budget
(Fulton, Scheffer et al. 2011).
One can therefore see that if a country were to employ too many expensive
physicians, it would exponentially decrease the amount of nurses that they’ll be able
to employ, which significantly decreases the availability of services. Conversely, if a
country only employs nurses, this could conceivably decrease the quality of service
patients experience as specialist medical services may not be available. Skills mix
decisions for a health service are influenced by health care worker associations,
licensure requirements and scope of practice and will impact on the availability of a
service as well as the affordability of scaling-up to universal access.
11.2. SCARCITY OF HUMAN RESOURCES FOR HEALTH
Sub-Saharan Africa, which has the greatest burden of health need, has some of the
lowest health worker to population ratios (World Health Organization 2006). There
are several factors that contribute towards a scarcity of HRH, including lower
economic incentives, poor working conditions and a straining education system. This
maldistribution of resources relative to need is often referred to as Hart’s inverse care
law, which was described by Julian Tudor Hart in 1971 and relates to the effects of
market forces in health care (Watt 2002).
The availability of good medical care tends to vary inversely with the












Hart further argued that ‘no market will ever shift corporate investment from where it
is most profitable to where it is most needed’ (Watt 2002). This can also be said to be
true of HRH, for which an international market has developed.
The maldistribution of HRH according to need is evident at multiple levels; at an
international level with the international migration of health workers from developing
countries to more developed countries, and within countries HRH distribution is often
skewed towards the urban areas and private sector health care. On average, about one
third of a country’s stock of HRH works in the private sector serving only a fraction
of the population (World Health Organization 2006).
In recent years high-income countries such as Australia, Canada, Saudi-Arabia, the
USA, the United Arab Emirates and the UK have been using their buying power in
the form of better salaries, living conditions and a more stable economy to purchase
scarce, trained health care workers from developing nations (Chen, Evans et al. 2004).
On the one hand, one could argue that the migration of health workers may have
economic benefits for both countries as capital-rich countries gain an influx of scarce
skilled labour and labour-rich countries are compensated in remittances (formal and
informal) which go directly to households, contributing to broad based income growth
in migrant sending areas and promoting poverty alleviation and development (Taylor
1999; Record and Mohiddin 2006).
However, where migration outstrips training, a shortage of staff would make it
extremely difficult for the ‘exporting’ country to deliver essential health services and
keep up the training output required. In the United Kingdom, almost one in ten
doctors were trained in Africa (Mills, Schabas et al. 2008). In terms of the impact of
large scale HRH migration on the delivery of essential health services, it has been
shown that as the density of health-care workers in a country decreases, the mortality
rate increases. Based on the effect on the health of the ‘exporting’ country, Mills et al
(2008) call for the active recruitment of health workers from developing countries by
developed countries to be considered unethical and should be prosecuted by the











The problem with Mills and colleagues’ argument is that it assumes that people have
no influence over their environment or circumstances, but as Robinson and Carey
suggest, migration decisions are ultimately not made in isolation but are influenced by
the wider political, social and economic context of a country (Robinson and Carey
2000). This viewpoint is echoed in Siegfried and Pienaar’s comment on Mills’ article,
which argues that it is important to consider the migration “push factors” of a country
such as South Africa, where it is not only health professionals who are migrating but
that they are part of a bigger wave of migration of skilled professionals. Siegfried and
Pienaar further quote the results of a survey conducted by the South African
Migration project which found that health professionals who emigrated said that the
general conditions in the country (including a lack of security, personal safety and
concern for their children’s futures) were a bigger “push factor” than poor working
conditions. Siegfried and Pienaar therefore concluded that the increasing of
regulations to stem the migration of health workers would undermine human rights at
an individual level (Siegfried and Pienaar 2008). The approach of Yassi et al., which
suggests that instead of well resourced countries having an ethical obligation to stop
migration, they have an obligation to improve the working conditions and knowledge
base in resource poor countries, seems more balanced and achievable (Chen, Evans et
al. 2004; Yassi, Bryce et al. 2009). Similarly Mackintosh argues that there should be a
form of restitution from countries accepting health professionals trained in Sub-
Saharan African countries towards the country training health professionals, in order
to compensate for the benefit from skills not created through investment in training
(Mackintosh 2007; McIntyre and Mooney 2007).
Similar to international migration, scarcity is often experienced within countries in
terms of a rural/ urban bias with a greater concentration of health care professionals
practicing in urban settings, which leads to people living in rural communities having
less access to health care, crowded clinics and lower quality of care (Reuter and
Couper 2007; Thiede, Akweongo et al. 2007; Hawthorne and Anderson 2009).
Strategies that have been used to improve the distribution of HRH include direct
financial incentives, benefits derived from training opportunities, or financial












 A review of discrete choice experiment studies to analyse health care providers’
preferences for different job characteristics in both developed and developing
countries, showed that non-financial incentives are often more powerful than financial
incentives. Non-financial strategies that are used to retain HRH include; encouraging
the recruitment of students who appear more likely to work in rural areas after
graduation, increasing the sensitization of health students to rural areas, the
improvement of working conditions in remote areas, more flexible working
arrangements and improving access to communication (Reuter and Couper 2007;
Lagarde and Blaauw 2009). A qualitative study conducted in South Africa which
examined different options for encouraging health care professionals to work in rural
practice, found that health care professionals with a rural origin, or having been
exposed to rural practice during training, as well as exposure to rural role models
were more likely to continue working in rural settings (Reuter and Couper 2007).
In conjunction with international migration, and a preference for urban over rural
posts, South Africa also experiences a strong pull of health workers away from the
public service and into the private sector, with approximately 43% of professional
nurses being employed in the public sector which serves more than 80% of the
population (Van Rensburg, Steyn et al. 2008). The reasons for this exodus relates to
low pay and poor working conditions (Hirschhorn, Oguda et al. 2006). In an effort to
mediate this effect on the health system, the South African government has mandated
a 3 year compulsory in-service training for doctors, two years of which is called
internship and 1 year of community service. Other health care professionals similarly
have to complete a year of community service working in a public institution after
completion of graduate studies. This provides some reprieve and there is the hope that
health professionals would choose to stay on in the public sector after internship and
community service. Another important strategy that has been used in South Africa to
retain health professionals in the public sector and to draw them back from the private
sector is the Occupation Specific Dispensation (OSD) which is a financial reward
structure aimed at improving the compensation of all health professionals in a fair
manner for their skills. Unfortunately due to the manner of the negotiations, the OSD
has left some doctors (especially mid-level doctors with some experience) feeling
unappreciated and not compensated to the same extent as their peers in private











It can therefore be concluded that where health professionals are severely underpaid
compared to their counterparts in private practice, financial incentives will present an
enticing carrot to leave the public sector. Therefore, a combination of financial
strategies as well as an improvement in working conditions for health workers may
assist in retaining health workers in the public sector.
11.3. TASK-SHIFTING
Apart from staff-retention and improved production strategies, a common response to
HRH shortages in poor-resourced settings is the use of substitute health workers, such
as mid-level workers or lay workers for non-technical tasks, to relieve pressures on
health professionals (Van Rensburg, Steyn et al. 2008). Task-shifting can be defined
as the delegation of tasks from highly skilled workers to cadres with either less
training (but still capable of doing the work) or more narrowly tailored training
(Callaghan and Schneider 2009). The primary aim of task-shifting is to increase
productive efficiency and that the efficiency gain may lead to improvements such as
increased patient access, lower health worker training and wage bill costs, and a
decrease in the health workforce shortage relative to need. Another objective of task-
shifting is to decrease the time needed to mobilise a scale-up in the workforce
according to the health needs of the population, as the cadres require shorter training
times (Fulton, Scheffer et al. 2011).
Different types of task-shifting have been described: (1) indirect substitution or
delegation of tasks to an existing but different profession (e.g. delegation of tasks
from a doctor to a nurse); (2) direct substitution to a less-trained/ mid-level worker
within the same profession (e.g delegation of tasks from a professional nurse to a
nurses assistant); (3) the delegation of non-technical tasks to lower trained or lay
cadres of staff (e.g. employing administrative staff or community health workers to
take over some of the roles and duties of nurses); and (4) the creation of a new level












While task-shifting has been occurring for decades, it is seen as becoming more
urgent, because of the health care needs of HIV/AIDS patients and needing to prevent
people with other conditions from being squeezed out of the health services
(Fleischer, Kevany et al. 2010). Until recently, much emphasis had been placed on the
assumption that staff needs for HIV care differ dramatically from primary care
services and are more “doctor intensive”. However, there have been proposals to
simplify treatment regimens and move towards task-shifting, together with an
emphasis on the involvement of local communities (Stevens and Lehman 2009). In
South Africa there has been a move towards a nurse-based, doctor-supported ART
service to be integrated into the District Health System (SANDH 2007; South African
National Department of Health 2007; Colvin, Fairall et al. 2010).
Task-shifting can have many benefits. In a multi-country study, Huicho et al. (2008)
found that in underserved rural areas where health care needs are the greatest, health
workers with longer pre-service training (i.e. doctors) are less available than those
with shorter pre-service training (i.e. nurses) (Huicho, Scherpbier et al. 2008). A study
performed in Mozambique found that there was less out-migration by mid-level
workers trained in the country than physicians. They found that 90% of mid-level
workers recruited from rural areas, returned and stayed in rural areas for a minimum
of seven years after graduation compared to 0% of physicians. This is thought to be
due to the ease with which physicians’ skills are transferable to other countries as
training is based on European standards (Dovlo 2004; Kruk, Pereira et al. 2007).
Task-shifting whereby people are trained on an in-service basis, could therefore assist
in the retention of skills where they are most needed.
Quality of care has been mentioned as an argument against task-shifting (Philips,
Zachariah et al. 2008). Research has however found evidence to the contrary. A
comprehensive multi-country study by Huicho and others, comparing the performance
of different categories of health workers trained in Integrated Management of
Childhood Illness (IMCI) and child mortality, found that the quality of care (defined
as compliance with IMCI guidelines for assessment and treatment of sick children)
did not differ between those with longer and shorter duration of pre-service training.
The IMCI treatment was delivered in primary health care facilities. One of the











more willing to comply with standard clinical guidelines than health workers with
more training who might be accustomed to taking short cuts or delegating some tasks
to clerks, such as counselling and dispensing medication (Huicho, Scherpbier et al.
2008).
The use of task-shifting in poorly-resourced areas could therefore alleviate the most
urgent needs by providing a health worker who is skilled, works according to standard
operating procedures and is less likely to migrate.
12. PHARMACEUTICAL CARE: THE ROLE OF THE PHARMACIST
Pharmaceutical services experience the same workload pressures and staff shortages
that plague other HRH. In fact, during the initial roll-out of ART in South Africa the
focus was on increasing access to drug supply, by for example lowering the cost of
ART drugs and negotiating for the production of generic drugs. However, limited
effort has been directed towards ensuring that the systems, processes and human
resources associated with the safe provision of drug therapy are available (King and
Fomundam 2009). This is becoming m re crucial as the ART programme is being
scaled-up and adherence to treatment over the long term is becoming a concern.
Studies in developed countries have found that support from pharmacists can
positively affect adherence and has a strong impact on promoting good clinical
outcomes in patients on ART (Horberg, Hurley et al. 2007). In developing countries,
the role of pharmacy staff in supporting the ART program varies considerably and
pharmacists’ skills are often underutilized (Walkowiak and Keene 2004).
Pharmacy as a profession, has in recent years reoriented its practice from a clinical
service model to a pharmaceutical care model (Blantyre 2007).  Pharmaceutical care
refers to the direct, responsible provision of medicine-related care designed to achieve
definite outcomes that improve a patient’s quality of life. Beyond simply handing out
medicine, the concept of pharmaceutical care refers to a far more responsible role of
promoting adherence to therapeutic regimens, investigating and addressing problems











errors and untreated indications. The lack of trained pharmacists therefore creates
severe disease management challenges in a country, despite the fact this extended role
of pharmacists are often not possible in a resource-limited setting (King and
Fomundam 2009).
12.1. PHARMACISTS IN PRIMARY HEALTH CARE
In 2005, the UK National Health Service (NHS) launched an initiative called
“Choosing Health through Pharmacy”, aimed at enhancing the pharmacist’s
contribution to improving public health and reducing health inequalities through
pharmaceutical care (United Kingdom department of health 2005). The initiative
presumes that on the basis of their knowledge, skills and proximity to the public,
pharmacists are an untapped resource for health in the United Kingdom.
Studies examining the benefits of pharmacists in rimary health care had mixed
results. Evidence suggests that pharmacist-led medication reviews, focused on high-
risk patients with conditions that alter drug handling by the body and where patients
receive multi-medication regimens, improves patient outcomes compared to no
comparable service (Nkansah, Mostovetsky et al. 2010). However, there is a paucity
of evidence on the impact of pharmacist-led medication reviews when the service is
provided by another health care professional, such as in nurse-led dispensing. The
difficulty in assigning a value to the service provided by pharmacists often lies in the
outcome measure used. Notably Holland et al. (2008) in their systematic review
excluded patients’ improvements in knowledge and adherence and focused on more
measurable effects such as hospital admissions and deaths in older people (Holland,
Desborough et al. 2008; Silcock and Petty 2008). It could be argued that the value of
pharmacist intervention lies in imparting knowledge and the changing of prescribing
practices. Monroe et al. (1997) and Dooley et al. (2003) concluded that pharmacists
are cost saving when one considers total monthly medical costs, as pharmacists put
measures in place to promote rational prescribing (Munroe, Kunz et al. 1997; Dooley,
Allen et al. 2003). There is however a lack of similar evidence in resource-poor











12.2. TASK-SHIFTING: THE PHARMACISTS ASSISTANT DEBATE
The World Health Organization’s (WHO) guidelines recommend a minimum country
average of 1 pharmacist per population of 2 300 people. An overview of the state of a
selection of developed and developing countries shows the range of population to
pharmacist ratios with developed countries (and countries who often actively recruit
health care workers from other countries) falling well under the WHO
recommendation of 2 300 people per pharmacist (see Table 1). Conversely, as can be
expected, developing countries, with less pharmacy schools have higher population to
pharmacist ratios.

















USA 114 249 642 1 153 287 842 000 ҂ yes ҂
CANADA 10 27 078 1 193 32 307 000 ҂ yes ҂
UK 27 29 726 1 953 58 042 000 ҂ yes ҂
CUBA 3 2 962 3 779 11 193 000 ҂ yes 7047
SA 9 11 097 4 332 48 073 000 ҂ yes 1 424
BOTSWANA 0 140 13 136 1 839 000 ҂ yes 193
SWAZILAND 0 46 24 435 1 124 000 46/0 ҂ 24
LESOTHO 0 17 117 353 1 995 000 ҂ yes ҂
UGANDA 4 215 133 484 28 699 000 209/9 ҂ 473
ZAMBIA 0 68 172 618 11 738 000 ҂ ҂ 332
MALAWI 1 37 424 108 15 692 000 ҂ ҂ ҂
Sanchez, AM.2010. Pharmacy Education in Cuba. Pharm World Sci.
‡academic_institutional_membership.fip.org/world-list-of-pharmacy-schools/




From Table 1, one can see that there is a severe shortage of pharmacists to provide
pharmaceutical care in South Africa (and many other developing countries). With the
overwhelming increase in demand for ART, it is no surprise that pharmacies and
pharmacists are unable to cope. This is aggravated by regulatory authorities which
might not have the funding or resources available to enforce applicable laws or to
carry out research to amend policies (King and Fomundam 2009).  Therefore, an array











provision is made in the law for nurses themselves to prescribe and dispense
medication.
Pharmacists Assistants (PA) are used in many countries as a form of mid-level
worker, who is practically skilled to perform a specific function but is not as highly
trained as the pharmacist. The PAs are therefore used to perform the so-called “lick
and stick” pharmacy operation, which frees the pharmacist up to check for medication
errors, spend time on counselling patients during dispensing and providing a more
patient-centred service (Canadian Pharmacists Association 2008).
South Africa has policies and regulations in place that could enable the task-shifting
of pharmaceutical services to professional nurses or PAs where pharmaceutical
services are lacking in order to ensure access to essential care. This enables
professional nurses to provide a complete service of managing and dispensing ART in
a Primary Health Care (PHC) setting. These practices would however take time away
from the clinical duties of the health professional and could restrict scale-up of
services. In light of the severe shortage of nurses in South Africa, this may not be a
viable solution (Schulman, Makani et al. 2009). The South African Pharmacy Council
allows for the registration of PAs, a category of mid-level worker who are trained and
employed in pharmacies, to perform administrative or repetitive tasks essential in the
operation of a pharmacy (South African National Department of Health 2007).
The Pharmacy Act 53 of 1974 deals with the scope of practice, training as well as
registration of PAs. It also allows for PAs working under the indirect supervision of a
pharmacist in government facilities. The provisions under which a PA can dispense
under indirect supervision, include that medication is provided in patient-ready packs
or re-packaged for this purpose at the hospital or provincial depot. It is further
specified that a PA working under indirect supervision must be visited once a month
by the Designated Supervisory Pharmacist (DSP) and that such visits should be
documented (Medecins Sans Frontieres 2007; Honermann 2009).
In South Africa’s PHC system, the PA is a crucial team member in the nurse-driven
service with only visiting doctor’s support (Du Preez 2009). However, many











and therefore see PAs as a threat as opposed to an opportunity (Gray, Gengiah et al.
2006). In conjunction with this, PAs are currently trained through a form of in-service
learnership with a pharmacist acting as tutor and responsible for their training. This
can be an onerous task in an already resource-limited pharmacy.
Following the release in 2006 of the SA Department of Health’s human resource plan
for health, there has been an increased push to develop mid-level workers for all
health professions. This has resulted in increased pressure on the SAPC to use the
lessons learnt from the PA programme and revamp the pharmaceutical care mid-level
worker (White 2007). The intention is to replace the concept of PAs, and to change
the training to include more academic content. The new grade of mid-level worker is
to be called a Pharmacy Technician and the intention is to give them more
responsibility but still under supervision (whether direct or indirect), with the
authority to supervise and train more junior assistants (Dring 2007; Osman 2010).
This will certainly assist pharmacists in improving pharmaceutical services in the
public sector and improve patients’ access to treatment.
12.3. MODELS OF ART DELIVERY
In Working Together for Health: The World Health Report 2006, the WHO highlights
that in many countries the skills of scarce and expensive health professionals are not
well matched to the local profile of need (WHO 2006). Therefore, even where
methods of task-shifting are used but not used appropriately or efficiently, instead of
improving access it would make health services less available, and where available
less affordable (Fulton, Scheffer et al. 2011).
The model of ART service delivery will influence the number and mix of staff
required to provide an ART service and this depends on several factors (see Figure 1).
These include the spectrum of care provided by sites, the level of integration into the
primary health care system, and the frequency and level of skills required per patient
visit. When it comes to the spectrum of care, a specialist, hospital based ART service
maximizes the use of specialists trained in ART care and support, resulting in higher











complicated ART patients from other sites, but due to the scarcity of ART specialists
this system limits patient access to treatment or greatly increases travel and time costs.
Conversely, the primary care service provision model allows providers to develop
expertise in ART, will require more staff per patient but allows for a more integrated
and decentralized approach, which ultimately facilitates access to ART. The
integration of ART service into the primary health care service will change staff
requirements and needs to be accompanied by the supply of additional HRH to
prevent the crowding out of other services and to decrease the risk that expansion of a
well-funded programme will weaken other health services by competing for the same
HRH (Hirschhorn, Oguda et al. 2006; Van Rensburg, Steyn et al. 2008; Hanefeld and
Musheke 2009).
With the need for the expansion of ART services in South Africa, the South African
government in conjunction with partners and stakeholders have authorised the down-
referral of patients stabilized on ART from hospitals to PHC clinics. This will
alleviate the patient load on the hospital pharmaceutical service as well as decrease
the cost of transportation to collect medication for patients. The shortage of
pharmacists at primary health care clinics has led to the deployment of pharmacists’
assistants and nurses to support the expansion of the ART programme and to ensure
that patients get their medication. In different provinces and districts of South Africa,
different approaches have been explored, but evidence on the effectiveness of these
measures in improving access to treatment is still lacking (Walkowiak and Keene
2004; Colvin, Fairall et al. 2010).
One option is that prescriptions are prepared at a nearby hospital and delivered to the
clinic closest to the patient’s home or place of work. The prescription is packaged
with the needed information and delivered for nurses to dispense (Colvin, Fairall et al.
2010). The nurse will then review the patient’s progress, and returns the progress
report and any uncollected medication to the hospital.
A recent development which is currently under scrutiny, involves the amendment of
the antiretroviral therapy guidelines to allow primary care nurses to “place their
patients on ART using predetermined national guidelines, re-prescribe using those











programme for nurses (NIM-ART), access to experienced physicians to provide
support, referral measures in place and ongoing clinical mentoring (Househam 2010).
This option has become feasible as the criteria for starting patients on ART has
changed and relatively healthier patients with better projected outcomes are now
starting treatment, who are easier to manage, although little evidence exists that this
will be a safe and effective method of ART service provision.
An option used in the Western Cape involves PAs dispensing ART in PHC clinics
under the indirect supervision of a pharmacist. Additional training is provided for
assistants, along with a clear description, standard operating procedures and
monitoring tools implemented to set standards for practice and to facilitate effective
oversight. An adaptation of the above scenario is where pharmacists visit the PHC
clinic once a week to dispense ART or check scripts prepared by a PA and the
medication is then handed to the patients by either the pharmacists or nurses working
in the PHC clinic (Walkowiak and Keene 2004; Monteith, Grimwood et al. 2010). An
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Dispenses directly to the
patients and is responsible
for stock control.
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allowed to supervise up to
5 pharmacists’ assistants.
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clients by the PA and
issued to staff for treatment
areas. Dispensary design
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Birch et al. (2003) suggests that the use of new HRH staffing models, may change the
HRH requirements associated with a given service (Birch, O'Brien-Pallas et al. 2003).
For example, the shift in ART service provision from a centralized doctor-driven
service to a decentralized service incorporated in the primary health care package
would conceivably reduce the number of highly specialized HRH needed but will
certainly increase the number of nurses and community health workers required
(Colvin, Fairall et al. 2010). Consequently, HRH monitoring and evaluation in
addition to evaluations of the impact of different mixes of HRH would be very useful
to assess human resource strategies in countries and sensitise political stakeholders to
the importance of addressing labour issues (Diallo, Zurn et al. 2003) .
13. METHODOLOGICAL CONSIDERATIONS
The difficulty with staff mix comparative studies is that external validity of the study,
by the very nature of the subject matter, should be considered low (Buchan and
Calman 2005; Fulton, Scheffer et al. 2011). This is because the factors of production
of HRH vary so considerably between countries and even between districts in the
same country. In addition it is the very differences in factors of HRH production and
the unique circumstances in the country’s health system (including health care
financing) that gave rise to specific task-shifting measures in the first place.
There is little consensus on the appropriate methodology to use in comparing HRH
mix (also called “staff mix”) in a health system, although Fulton et al. (2011) has
suggested that cost-effectiveness analyses would be useful in ensuring that the correct
comparisons are made (Fulton, Scheffer et al. 2011). Until recently, the focus of staff
mix evaluations have been on the delegation of tasks from doctors to physician
assistants (Chilopora, Pereira et al. 2007; Herbertson, Blundell et al. 2007; Kruk,
Pereira et al. 2007; Pereira, Cumbi et al. 2007; De Brouwere, Dieng et al. 2009;
Hounton, Newlands et al. 2009; McCord, Mbaruku et al. 2009; Brentlinger, Assan et
al. 2010); from doctors to nurses (Kinnersley, Anderson et al. 2000; Buchan and
Calman 2005; Barber, Gertler et al. 2007; Huicho, Scherpbier et al. 2008;











Orrell et al. 2010); and from nurses to community health workers (Rowe, Kelly et al.
2007; Rahman, Malik et al. 2008; Gary, Batts-Turner et al. 2009; Wools-Kaloustian,
Sidle et al. 2009; Lewin, Munabi-Babigumira et al. 2010; Selke, Kimaiyo et al. 2010),
with a paucity of studies referring to pharmaceutical care staff (Monteith, Grimwood
et al. 2010).
Key economic evaluation methodological considerations include deciding on the
comparators to contrast and defining the outcome measures to be evaluated
(Drummond, Sculpher et al. 2005). Concerns raised by Verteuil (2007) and Fulton
(2011) in relation to Kruk et al.’s Mozambique study comparing the cost and
productivity of surgically trained assistant medical officers and specialist physicians
related to the importance of including a ‘do nothing’ comparator when comparing
different task-shifting scenarios (Fulton, Scheffer et al. 2011). They argue that … “a
more realistic alternative for patients treated by tecnicos de cirurgia (surgically
trained assistant medical officers) would be no formal treatment at all, which would, it
is presumed, result in far worse outcomes for the patients” (Kruk, Pereira et al. 2007;
Fulton, Scheffer et al. 2011). While Verteuil is correct in that a “do nothing”
comparator would be useful, given that the political and social intent for a country’s
health system is to provide access to care, the question to be answered by task-shifting
evaluations really is only which approach is more likely to improve access to care at
the lowest cost and at a certain quality of care. The use of an incremental or marginal
analysis approach would help to ensure appropriate comparisons as costs which are
common to all options are excluded (Drummond, Sculpher et al. 2005).
Another key methodological consideration for economic evaluations is the outcome
measure to be evaluated. These have differed between studies and interventions. For
example, in their evaluation of diabetes primary care provided by nurses and
community health workers as opposed to standard care, Gary et al. (2009) used a
clinical measure of blood sugar control (HbA1c levels) and emergency room
utilization as the outcome measure (Gary, Batts-Turner et al. 2009). In contrast, a
study conducted by Babigumira et al. (2009) focused on determining the impact of
task-shifting on the costs of ART supply, and concluded that task-shifting was cost-
saving when delegating follow-up visit tasks from doctors to nurses and pharmacy











(2009) took into account the potential saving of Full-Time Equivalent (FTE) doctors
due to task-shifting, their study did not include the opportunity cost of task-shifting to
nurses and pharmacy staff. This is because a cadre that has taken on additional tasks
shifted from other cadres will no longer be able to perform its original tasks and an
increase in workload will be experienced by these cadres. The study may therefore be
overestimating the cost-saving benefits of task-shifting (Van Rensburg, Steyn et al.
2008; Fulton, Scheffer et al. 2011). In addition, Callaghan et al. (2010) made an
important point when saying that while task-shifting/ different staff mixes may be
cost-effective, it may not necessarily be cost-saving because a greater number of
people will be able to access health services which places an additional burden on the
health services and it is important to consider these factors when recommending a
combination of HRH (Callaghan, Ford et al. 2010).
14. ACCESS TO ART SERVICES
The importance of task-shifting is that it improves access to care insofar as it enables
health services to rapidly scale-up an intervention and to provide health care in close
geographical proximity to people’s homes (Fulton, Scheffer et al. 2011).
While utilization of health services has often been used as a proxy for access to health
care, and certainly skewed utilization of a service may be the first indicator that there
are problems in access to the service, the reverse is not true - what is considered to be
“good” utilization of a service does not tell us whether people have access to a service
(Thiede, Akweongo et al. 2007). For acceptable reasons, those with equal need and
equal access to health care may not make equal use of services, with individual
preferences being a key factor. Essentially, the concept of access is not the same as
service use. A useful definition of access is that it refers to interactions between health
services and the individuals or households that make up the community (Thiede,
Akweongo et al. 2007; McIntyre, Thiede et al. 2009). More specifically, it relates to
an individual’s ability to derive benefits from health care services, and not simply a
health system’s capacity to provide the services (McIntyre, Thiede et al. 2009).
Access, as opposed to use of services recognises that a service may be available but











the service is available but the community does not have the necessary knowledge on
how to make use of the service or that the service exists, the community cannot be
said to have access to the health service.
The demand and supply side factors which influence individuals’ ability to access
health services can be evaluated in terms of three dimensions; acceptability,
affordability and availability (Ensor and Cooper 2004; Thiede, Akweongo et al.
2007). Demand side factors refer to patient-level factors as opposed to supply side
factors relating to the service provider, the health system and the social and political
landscape of a country.
14.1. AVAILABILITY
Availability is defined, within the context of the access framework, as having the
appropriate health service available in the right place when needed and of good
quality. It includes issues such as the relationship between the location of a service
relative to location of the community and the range and type of services relative to
burden of disease; the availability and need for transport and includes the ability of
health care providers to provide mobile services or home visits; the hours of opening
of health care facilities and whether or not an appointment system is being used; the
drug supply system used in a service in so far as whether the appropriate medication
is available for the patient when needed; as well as the appropriate or sufficient staff
mix relative to the health needs of the population (Thiede, Akweongo et al. 2007).
14.1.1. Transport as a barrier to access
The location of health care facilities and health services relative to the location of
those who need the services and their transportation opportunities impacts on
individuals’ ability to access treatment and therefore it’s availability (Ensor and
Cooper 2004; McIntyre, Thiede et al. 2006; Weidle, Wamai et al. 2006; Tuller,
Bangsberg et al. 2009; Wasti, Simkhada et al. 2009). This is of concern in South











ART was concentrated around hospitals and the urban areas, which leads to a barrier
to treatment for those who have to travel far to receive treatment. In Uganda, the
concern around transportation constraints was addressed by providing a home-based
AIDS care service in the rural Tororo and Busia districts, with measurable success
(Weidle, Wamai et al. 2006). Similarly, evidence from a Medicines Sans Frontiers
(MSF) clinic in Lusikisiki, South Africa has shown that decentralized HIV/AIDS
care, due to greater proximity and acceptability of services, has led to faster enrolment
and better retention compared to a centralized hospital based approach (Bedelu, Ford
et al. 2007).
14.1.2. Drug “stock-outs” as a potential barrier to access
Drug “stock-out” refers to the unexpected lack of availability of certain essential
drugs at a facility. This has a serious impact on the availability of health care, as even
if the drugs are expected to be in stock in a week’s time, this would result in a second
trip for the patient to the clinic with all the monetary costs and time lost associated
with it. Furthermore, a “drug stock-out” could indicate a break in treatment for the
patient, which has disastrous effects in the case of ART where adherence is vital to
preventing viral mutation and treatment failure.
“Drug stock-out” is seldom caused by a single factor but it’s rather due to a
combination of circumstances. In a comprehensive situational analysis of a district in
Limpopo South Africa, Matse (2005) found the following the factors to be associated
with drug shortages in primary health care (PHC) facilities:
- Pharmacy staff often did not know how to use formulas associated with the
quantification of drugs to be ordered. They therefore often guessed or
estimated how much drugs were to be ordered.
- The drug procurement and distribution company was directly contributing to
drug shortages by themselves having multiple “stock-outs” of essential drugs.
- The facilities often did not have a stock control system in place, while it has
been found that if stock cards are used correctly it could be used to accurately











- The researcher further found that irrational drug prescribing as well as the use
of multiple drugs for the same condition (poly-pharmacy) was a key reason for
drug stock-outs. Irrational drug prescribing is often the result of poorly trained
prescribing staff as well as the lack of supervision by a pharmacist.
- Lastly, while storage and security is in many other countries a contributing
factor to drug stock-outs, the researcher could find no evidence of such factors
in South Africa (Matse 2005).
The result of the study therefore underscores the importance of the supervision by a
pharmacist, in conjunction with adequately trained prescribers to prevent “drug stock-
outs”, thereby improving patient outcomes as well as being cost saving if one
considers that medication is the second greatest item on the medical facility budget
after staff costs. For patients, regular drug stock-outs at the clinics can lead to
‘shopping around, non-consultation and self-treatment rather than wasting funds on
transport for a fruitless trip to the local clinic’ (Goudge, Gilson et al. 2009).
14.2. AFFORDABILITY
Even when health care is provided free of charge, it is widely recognised that
accessing treatment comes at a cost to patients (McIntyre, Thiede et al. 2006; Tuller,
Bangsberg et al. 2009). Patients incur economic costs in the form of the cost of
transport to and from the facility, resources spent on additional medical treatments,
healthy food and home care, as well as the opportunity costs of productive time spent
away from work (McIntyre, Thiede et al. 2006). Research conducted in South Africa
has suggested that non-drug costs incurred by patients may act as a significant barrier
to accessing treatment (Rosen, Ketlhapile et al. 2007). This has been substantiated by
research from South-western Uganda (Tuller, Bangsberg et al. 2009).
It is important to distinguish between willingness and ability to pay. Assuming that a
service is affordable because people are utilizing it does not take into account that
households will often prioritise health care and healthy food for those members who
are critically ill, and forgo other essential needs such as education, with serious











Affordability can therefore be defined as the degree of fit between the cost of using a
health care service and the individual/ household/ society’s ability to pay for it. The
direct and indirect costs associated with health care may not be a barrier to treatment
if people are receiving government subsidies, they have access to credit or if they
have a regular income and therefore receive paid sick-leave. Often though, the
expenses related to health care, in conjunction with people’s inability to earn due to
being ill and working in an informal sector, cuts into household savings and pushes
household into what has been termed the “medical poverty trap” which refers to the
cycle of being sick, needing money for treatment but being unable to earn money due
to the illness (McIntyre, Thiede et al. 2006).
14.3. ACCEPTABILITY
Even when a service is geographically available and is affordable, it may not
necessarily be acceptable and therefore not accessible. Acceptability relates to the
degree of fit between provider and patient attitudes towards and expectations of one
another. Patient attitudes towards provider characteristics such as gender, race, age
and language may influence the patient’s ability to receive care (McIntyre, Thiede et
al. 2006). Respect and trust between patients and providers along with power
relationships are often the underlying root causes of acceptability barriers to access.
Gilson et al. (2005) in their study exploring user and provider views on public and
private health services in South Africa found that respect was linked to provider
attitudes and interlinked with the perceived competence of the provider. The authors
further concluded that respectful treatment is the central demand of primary care
service users in South Africa (Gilson, Palmer et al. 2005). Evidence from Tanzania
suggests that community perceptions on the quality of local health care provided
influences women’s decisions on where to give birth (Kruk, Rockers et al. 2010).
Akin et al. (1999) found similar results in Sri Lanka which suggests that patients are
willing to bypass one facility, to travel further to use another facility which offers a
better perceived quality of care. In addition, the Sri Lankan study suggests that
patients are more likely to travel further for good quality care the more ill they are
(Akin and Hutchinson 1999). While the perceived quality of care of a health service is











training and motivation, the underlying factor relates to respect for patients and co-
workers and presence of good leadership in the health management team.
Acceptability of health services also differs between males and females. In Southern
Africa, it has been found that there are more females on ART than males which
cannot solely be explained by the higher HIV prevalence among females compared to
males (Muula, Ngulube et al. 2007). It has been suggested that the emphasis on HIV
testing among women attending antenatal care means that women are diagnosed much
earlier than their male counterparts. This has resulted in a pattern whereby women are
the ones bringing home the diagnosis of HIV, and anecdotally it has been suggested
that men test by proxy i.e. if their girlfriends are negative they must be too. These
circumstances in conjunction with a very female-centred approach at primary health
care clinics in South Africa creates barriers for men to testing and receiving HIV care
at the local clinic (Braitstein, Boulle et al. 2008; Kipp, Alibhai et al. 2010).
14.3.1. Stigma
Stigma, discrimination and avoidance of stigma is a recurrent theme and struggle in
ART programmes, based on evidence from Nepal (Wasti, Simkhada et al. 2009),
Uganda (Muhamadi, Nsabaga ani et al. 2010), and Tanzania (Parkes-Ratanshi,
Bufumbo et al. 2010). It is often mentioned as a factor that delays testing and results
in poor adherence to treatment (Seidel 1996; Weidle, Wamai et al. 2006; Wasti,
Simkhada et al. 2009; Muhamadi, Nsabagasani et al. 2010; Parkes-Ratanshi, Bufumbo
et al. 2010).
Steinberg (2008) in his book wherein he follows a young man through the process of
acknowledging the disease in his community, to testing and finally acknowledging
that he is HIV positive commented that:
When people die en masse within walking distance of treatment, my inclination is to believe that there












Stigma relates to the way in which we present health care services and can be defined
as a social process whereby a discredited attribute is used to devalue a person. The
process is rooted in power. The legitimate identity is acknowledged by cultural norms
introduced by the dominant groups or institutions of a society, and the spoiled identity
by its nature does not conform or has in some way broken the norms. There seems to
be disagreement in the literature as to the inevitability of discrimination as an
outcome. Goudge and others (2009) suggested that the marginalised daily resists the
negative labelling of HIV identities and negotiates the creation of new positive HIV
identities (Goudge, Ngoma et al. 2009). They further suggest that it is in the
individual finding meaning through social roles that they have the strength to resist
stigma.
Other studies highlight the importance of support and counselling in promoting
adherence to treatment, as well as highlighting the damage of secrecy around people’s
HIV status (Seidel 1996), with reports of patients not taking their medication at home
for fear of being discovered to be HIV positive (Wasti, Simkhada et al. 2009).  A
limitation of many of these studies, that are seeking information on why people don’t
access treatment, is that they seldom interview people who don’t access treatment, as
they are often in denial of their status and difficult to identify.
A common perception among ART service funders and clinical managers is that
stigma would decrease where treatment is available, perhaps due to the control of
symptoms leading to less outwardly visible signs of the disease, or perhaps the
counselling and awareness of communities where treatment is available (Steinberg
2008; Goudge, Ngoma et al. 2009).  However, Maughan-Brown (2010) found a
significant rise in stigma in the Western Cape between 2003 and 2006 (which was a
period of ART roll-out) when measured on the basis of questions related to
behavioural intentions, instrumental stigma (negative judgement based on inflated
fears) and symbolic stigma (negative moral judgement). They further found that while
fear of infection increased for everyone, the increase was greater among men, and the
increase in negative moral judgements was the greatest among women. Considering
that the underlying cause of stigma is fear, Maughan-Brown (2010) concluded that it
is imperative to weaken associations between HIV and death, which could be











people living with HIV and AIDS have to live long and healthy lives on HAART
(Maughan-Brown 2010).
There are still significant barriers for people in accessing ART, and it is important that
these are identified, discussed and addressed within communities to promote the cost-
effective use of funding for ART programmes and work towards equal access to ART
for those who need it.
15. SUMMARY
Access to essential medicine is often constrained in developing countries. These
reasons are context specific and include the lack of sustainable funding, poor planning
and management of drug procurement and distribution processes as well as the
shortage of pharmaceutically trained HRH. More broadly, a lack of sufficient HRH
has been identified as one of the main constraints to achieving universal ART
coverage. Some of the provider and system factors impacting on HRH production are
graphically summarised in Figure 1. The maldistribution of HRH according to need
has been shown to be on an international basis whereby internationally mobile HRH
from developing countries are attracted to developed countries where salaries are
higher. However, nationally there is often an additional maldistribution of HRH
between urban and rural settings as well as between the private and public health
sectors.
Given the scarcity of HRH, various models of pharmaceutical care delivery have been
debated globally, however little evidence has been found of evaluations of these
different models. One approach includes different task-shifting arrangements. Task-
shifting refers to the delegation of tasks from the more highly qualified health worker
to a narrowly trained worker. While quality has been discussed as a concern, the
studies seem to indicate that the quality of care delivered by mid-level workers is at
least comparable to that of the internationally mobile HRH. In addition, mid-level
workers are more likely to work in more rural facilities where the need is greatest











The major benefit of task-shifting is that it can improve patients’ access to treatment.
Access has been defined across three dimensions including availability, affordability
and acceptability. Availability relates to the relationship between the physical
availability of drugs, human resources and the needed infrastructure relative to the
needs of the community (the burden of disease). Affordability relates to the degree of
fit between the economic costs incurred by patients in accessing treatment or the costs
incurred by the health system in providing the service and society or the household’s
ability to pay. Finally, Acceptability refers to the appropriateness of a service
provided, as well as the expectations of both HRH and patients. The literature review
provides in-depth information on the concept of Access.
In the literature review, key methodological issues relating to economic evaluations of
HRH interventions as highlighted by other papers and experiences are discussed.
Most of the studies available discuss the shifting of tasks from the doctor towards the
nurse, while no studies was found that considers pharmacy HRH.
The urgency of addressing the lack of HRH in high disease burden countries, the
contributing reasons as well as possible policy recommendations have been
highlighted in the literature review.  While task-shifting has been recommended as an
effective option for limiting the impact of the scarcity of HRH, there are few
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A scarcity of human resources for health has been identified as one of the primary constraints to the
scale-up of the provision of Anti-Retroviral Treatment (ART). In South Africa there is a particularly
severe lack of pharmacists. The study aims to compare two task-shifting approaches to the dispensing
of ART, Indirectly Supervised Pharmacists Assistants (ISPA) and Nurse-based pharmaceutical care
models against the standard of care which involves a pharmacist dispensing ART.
Methods
A cross-sectional mixed methods study design was used. Patient exit interviews, time and motion
studies, expert interviews and staff costs were used to conduct a costing from the societal perspective.
Six facilities were sampled in the Western Cape province of South Africa, and 230 patient interviews
conducted.
Results
The ISPA model was found to be the least costly task-shifting pharmaceutical model. However,
patients preferred receiving medication from the nurse. This related to a fear of stigma and being
identified by virtue of receiving ART at the pharmacy.
Conclusions
While these models are not mutually exclusive, and a variety of pharmaceutical care models will be
necessary for scale up, it’s useful to consider the impact of implementing these models on the provider,
patient access to treatment and difficulties in implementation.













The scarcity of Human Resources for Health (HRH) has been identified as one of the
primary constraints to the provision of Anti-retroviral Treatment (ART) to all who
need it [1-3]. Pharmaceutical services experience similar workload pressures and staff
shortages to those that plague other HRH. While the World Health Organisation’s
(WHO) guidelines recommend a minimum country average of 1 pharmacist per 2,300
people, many Low- and Middle-Income Countries (LMIC) have averages far above
that level. South Africa has 1 pharmacist per 4,332 people [4]. In conjunction with
international migration, and a preference for urban over rural posts, South Africa also
experiences a strong pull of pharmacists away from the public health service and into
the private sector, with approximately 24% of registered pharmacists employed in the
public sector which serves more than 80% of the population [5]. This has led to a gap
in the systems and processes associated with the safe provision of chronic (and
specifically ART) drug treatment which is crucial as adherence is becoming of greater
concern [4].
The substitution of scarce health workers with purpose trained mid-level workers
(termed task-shifting) is a logical strategy to address the scarcity of HRH [6]. The
primary aim of task-shifting is to facilitate increased patient access to health services,
through enabling a rapid scale-up of much needed health care interventions, and lower
HRH training and salary costs [7]. In addition to the cost and efficiency benefits, mid-
level workers have been found to be more likely to remain and work in rural areas and
follow treatment guidelines. While quality of care has been cited as a concern by
critics, studies suggest that the quality of care provided by mid-level workers is at
least comparable to that of their more highly qualified colleagues [8-11]. A
randomised non-inferiority trial conducted in primary health care clinics in SA, which
compared doctor- versus nurse-monitored ART care found that nurse-monitored care
was comparable to doctor monitored ART care and therefore supported task-shifting
[11].
The shortage of pharmacists in the public health sector of South Africa (SA) has led to











programme and to ensure that patients receive medication. For the purposes of this
study we specifically considered activities relating to stock control, administrative
tasks such as collecting medication from a central dispensing unit where applicable,
the interpretation and evaluation of the prescription, the preparation and labelling of
the prescribed medicine as well as counselling of the patient on the safe and effective
use of the medication (adapted from the Pharmacy Act) as duties pertaining to
pharmacy staff. In different provinces and districts of SA, different models of
pharmaceutical care have been explored, but evidence of the costs and benefits of
these models is lacking. In addition, there is little consensus in the literature on the
appropriate methodology to use in comparing HRH staff mix in a health system,
although Fulton et al. (2011) have suggested that cost-effectiveness analyses would be
useful in ensuring that the correct comparisons are made [7]. Thus far, the focus of
staff mix evaluations has been on the delegation of tasks from doctors to physician
assistants [9, 12-18], from doctors to nurses [11, 19-24], and from nurses to
community health workers [25-30], with a paucity of studies referring to
pharmaceutical care staff [31]. This study therefore aims to critically evaluate the
indirectly supervised pharmacists assistant (ISPA) and nurse-based pharmaceutical
care models against the standard of care which involves a pharmacist dispensing
ART, on the basis of cost, waiting and travel time and patient preference.
Methods
Study design and setting
A cross-sectional, mixed method study design was used. Data was collected using
patient exit interviews, time and motion studies, and expert interviews. The study was
conducted in a district in the Western Cape Province of South Africa with a
combination of small-town and rural areas.
Sampling
Within the district, health care facilities were grouped based on the pharmaceutical











number of respondents were sampled, and the desired sample size per facility was
proportional to the number of patients on treatment at the facility. Systematic
sampling was used to select adult respondents on ART to interview while waiting for
medication. The sample size required to detect statistically significant differences
between the groups were calculated using a one-way ANOVA power analysis.
Data collection
A questionnaire was developed, piloted and interviewer-administered, to collect data
regarding the direct and indirect costs incurred in accessing treatment as well as the
acceptability of the service provided. The questionnaire was based on the
questionnaire used in a multi-centre collaborative study, Researching Equity in
Access to Health Care (REACH). Direct costs included the cost of transport, any
facility fees incurred, the cost of employing someone to take over tasks (such as
childminding), accommodation if sleeping over, and the cost of food, and
telecommunication while waiting at the facility. Indirect costs were estimated by
asking respondents about income lost from taking time to come to the facility, as well
as the cost of time spent travelling to the facility. Patient waiting time was estimated
by attaching a printed form to each patient’s folder, noting the time at which they
entered the facility and pharmacy or nurse dispensers were asked to note the time at
which respondents received their medicine. Collecting medication was considered to
be the last contact point in the service chain. The difference in time was aggregated
per facility and added to the average travel time to estimate the indirect cost per
respondent per visit.
Health service expenditure and staffing data was obtained through facility observation
and expert interviews with service managers. In order to determine the time spent by
nurses on dispensing related activities, the researcher observed practice and asked
nurses to estimate time spent dispensing if a total of 100% represents one work day.
In the analysis, the observed time was used and the nurse-estimates on time were used
in the sensitivity analysis. The cost of HRH was estimated from Department of Health












The potential cost of upgrading a medicine room to a dispensary, as required by the
Pharmacy Act for a pharmacists assistant to work in, was determined from a case
study of a facility within the same district that the research was conducted, and
sourced from the non-governmental organisation (NGO) which paid for the upgrade.
Respondent preferences were explored by asking whether they would prefer
collecting medication from a local clinic or hospital, in addition to asking whether a
nurse or pharmacist/pharmacists assistant dispensing was preferable. Respondents
were also asked to explain their preferences.
Data analysis
Statistical analysis of data was conducted using STATA 10 [32]. For examining
health care costs, Microsoft Excel was used. All costs are presented in 2009/2010
prices and estimated costs were converted to US Dollars at the average exchange rate
of the US Dollar to South African Rand for the 2010 financial year of $1 = R7.80
[33].
The cost analysis was conducted from a societal perspective, and includes health
service and patient costs. Given that the nature of the study is comparative, a marginal
approach to costing was adopted and costs that are common across pharmaceutical
care models were excluded [34]. For example, given that the cost of ARV drugs per
patient does not vary between models, these costs were excluded [35]. Costs covered
by donor funding as well as the cost of staff employed by donors were included, in
line with donor mandate that these functions are to be taken over by the Department
of Health in the future [36]. A key characteristic of the societal perspective in
economic evaluation is the inclusion of time – and opportunity cost and community
preference, but its inclusion is debated in literature [37-39]. Drummond et al. (2005)
argue that during short-term absences, losses in production could be compensated for
by staff on their return to work or by colleagues [39]. However, in order to account
for patients’ waiting and transport time, which differed significantly between
facilities, and could be seen as a measure of efficiency of service provision,











in South Africa, $0.94 per hour [40]. The total cost at the patient level per visit was
then calculated by adding the average direct and indirect costs, and the cost incurred
by society was calculated by adding the health service costs and the total cost to the
patient. Preliminary results of the analysis were discussed with service managers to
confirm assumptions and validate results.
The open-ended or discussion questions of the exit interview responses were analysed
using domain analysis during which topics were identified, assigned a code, and
domains and sub-categories explored. A list of codes was generated and used to
explore the common (and different) perspectives of the respondents [41].
Ethics
The research was approved by the University of Cape Town Health Science Faculty
Human Research Ethics Committee as well as by the Western Cape Department of
Health. The study was conducted in adherence to the Declaration of Helsinki of the
25th World Medical Assembly and all respondents participated on the basis of written
informed consent [42].
Results
Only 19 patients refused to be interviewed. Of the 230 patient exit interviews
conducted, 6 were excluded from the analysis as respondents were either not on ART












The characteristics of respondents are summarized in Table 1.
Table 1
Profile of respondents





mean age ± standard deviation 36.2 ± 9.2  years
Employment
unemployed 140 62.8%
employed full-time 41 18.4%
employed part time 42 18.8%
The unequal gender distribution of people who access ART in public health facilities
has been well documented [43-45]. The age distribution of respondents, with a mean
age of 36 years, is in line with the national profile of those on ART [46]. The
unemployment rate of respondents is significantly higher at 62.8% than the overall
Western Cape provincial estimate of 20.3% of the working age people [47]. This can
partly be attributed to the organisation of the SA health system whereby those
employed are more likely to use private health care paid for by medical insurance.
Facility characteristics
The study was conducted in a district with a combination of small-town and rural













Summary characteristics of ART service by facility
Group A: full-time pharmacist Group B: pharmacist assistant underindirect supervision Group C: nurse-driven
Pharm clinic 1 Pharm clinic 2 ISPA clinic 1 ISPA clinic 2 Nurse clinic 1 Nurse clinic 2
Level of service CDC* clinic CDC CDC clinic CDC
Pharmaceutical care
delivery system
A full-time pharmacist and
pharmacists assistant
dispenses medication on
request, and sends the
patient-ready packs to


























ordered from the central
pharmacy.
1 Pharm 0.66 Pharm 0.2 SPharm** 0.2 SPharm 0.2 SPharm 0.2 SPharm
1 PA 0.66 PA 1 PA 1 PA 0.2 PA 0.2 PA
Staff assisting in
pharmaceutical care
related activities 0.6 Nurse 0.66 PA 0.6 Nurse  0.36 Nurse 0.2 Nurse
0.6 Nurse 0.08 Nurse
Number of patients on
ART 1874 829 454 621 228 210
Ratio of FTE staff to
patients enrolled in care
 1 : 586  1 : 419  1 : 378  1 : 345  1 : 300  1 : 309
Average number of
months on ART (SD)
38 (12-52) months 28 (15-49) months 10 (4-21) months 7 (4-15) months 11 (5-15) months 11 (6-23) months
* Community day centre (CDC): a facility which is not open 24 hours a day, 7 days a week, but at which a broad range of primary health care services are provided. It also offers accident and
emergency services but not midwifery or surgery under general anaesthesia. Also have access to xrays, full-time pharmacist and full-time dentist (vd Merwe, personal communication)











Pharm clinic 1 represents a relatively well resourced health centre, and had one full-
time Pharmacist (Pharm), and a Pharmacists Assistant (PA) exclusively dispensing
ART, with two nurses using an estimated 60% of their working day in dispensing
related activities. This included, taking prescriptions to the pharmacy to be filled,
collecting medication and counselling patients on drug use. This arrangement came
after patients expressed their discomfort at waiting at the general pharmacy window to
collect their medication. Pharm clinic 1 had the greatest proportion of Full-Time
Equivalent (FTE) dispensing staff at 3.2 FTE compared to Pharm clinic 2 with 1.98
FTE. However, the ratio of patients on ART to FTE staff at Pharm clinic 1 was at
586:1 far greater than 419:1 at Pharm clinic 2.
The Indirectly Supervised Pharmacists assistant (ISPA) facilities had similar absolute
FTEs (1.2 versus 1.8) and ratios of patients on ART to FTE at 378:1 and 345:1
respectively. This does not explain the high average waiting time at ISPA clinic 1 of
four hours and seventeen minutes (see Figure 1). This facility was struggling under
the lack of a fulltime ART physician, which slowed down the renewal of prescriptions
and ultimately the dispensing process. ISPA clinic 2 also had significant assistance in
the dispensing process by the nurse; this included the ordering of medication for
patients, and ensuring that the prescription is in order for patients only coming for
repeat medication.
 The nurse-driven group had the fewest number of FTE dispensers as nurses often
only providing a once or twice weekly outreach service to the site. Notably the ratio
of patients on ART to FTE dispenser was considerably lower in the pharmacist model
than in either of the other pharmaceutical care models at 300:1 and 308:1 respectively.
This may be due to, increased efficiency of “learning through doing” as the
pharmacist model facilities have been operational for longer, have the largest patient
numbers and therefore achieve elements of economies of scale, and have more stable
patients on treatment requiring less input time in terms of counselling, which could all
contribute to less FTE staff members needed. Another factor may be that staff trained
in dispensing (i.e. pharmacists and pharmacists assistants) could bring greater
productive efficiency to the dispensing process and the service therefore takes longer
to reach “saturation point” where new dispensing staff members are needed. It is












Given that the main difference between the pharmaceutical care models relates to the
cost of HRH, it was the primary focus in the cost analysis from the provider
perspective. The provider (or staff) cost per patient visit (summarised in Table 3) for
the nurse-driven pharmaceutical care model was at $10.16 almost double that of the
pharmacist- or ISPA- models ($6.55 and $5.74). This can be attributed largely to the
difference in salaries between a pharmacists assistant and a nurse. In some of the
facilities, the boundaries of the dispensing team were blurred, and observation and
interviews with staff members was therefore used to identify time spent on
dispensing-related activities. Where there was a pharmacist provided services but
nurses were still involved in medicine related counselling, the time of nurses was also
included (see Pharm clinic 1 and ISPA clinic 2 in Table 2). The time cost of a PA pre-
packaging the medicine into patient-ready packets as well as the time spent by a
Pharmacist on supervising the dispensing was accounted for in all non-pharmacist
models (see ISPA and nurse clinics in Table 2).  Specifically, the time spent by the
PA and Supervisory Pharmacist (SPharm) preparing patient-ready packets for nurses
to dispense was included in the cost analysis.
In the ART programme, nurses working on outreach services are generally more
experienced and compensated at a higher salary level. It is therefore important to
consider the trade-off involved in shifting dispensing related tasks from pharmacists
to nurses given the scarcity of nurses. One could argue that the nurse’s time may
better spent performing clinical duties for which s/he is trained.
As would be expected, the direct costs incurred by patients accessing treatment,
reflected the level of decentralization of the service. Patients paid the most at the
pharmacist- led model facilities, where they spent almost four times more on transport












Average cost per patient visit (n=244)
Group A: full-time pharmacist
Group B: pharmacist assistant
under indirect supervision Group C: nurse-driven
Pharm clinic 1 Pharm clinic 2 ISPA clinic 1 ISPA clinic 2 Nurse clinic 1 Nurse clinic 2
Average provider cost
Staff costs $6.08 $7.01 $5.09 $6.38 $11.19 $9.13
Total cost to provider per patient visit $6.08 $7.01 $5.09 $6.38 $11.19 $9.13
Average patient costs
Direct costs $6.20 $3.35 $1.59 $1.65 $1.14 $3.00
Indirect costs $5.42 $5.09 $7.47 $4.15 $3.60 $4.84
Total cost to patient per visit $11.62 $8.45 $9.06 $5.81 $4.74 $7.84
Total societal costs for ART care per visit $17.70 $15.46 $14.16 $12.19 $15.93 $16.97
Percentage of respondents who incurred direct
costs, and found it unaffordable (n)
90% (36) 70% (14) 77.78% (21) 68% (17) 64.29% (9) 70.97% (22)












The cost of transport has been found to be a significant barrier to patient access to
ART in other studies [48, 49]. Similarly, when asked about the affordability of direct
costs incurred in attending the clinic, 90% of respondents at pharmacist-led, and 67%
at nurse-driven pharmaceutical care model facilities indicated that the costs incurred
are unaffordable. This is certainly not surprising, given the high level of
unemployment among respondents.
The average travel time is slightly less than reported by other studies. Rosen et al.
(2007) documented travel times (round trip) of between 83 and 158 minutes [50]. In
this study, travel time was between 45 and 127 minutes per round trip (shown in
Figure 1). However, it is interesting to note that respondents in Rosen’s study were
unlikely to walk to the facility while we found that up to 97% of patients from the
more decentralised sites walked to the facility. This would also impact on the
transport (direct) costs reported.
Figure 1










































Avg travel time (min)
Avg patient waiting time (min)
The costs per patient visit is summarised by pharmaceutical care model in Table 4.
The annual cost per patient was calculated by multiplying the cost to provider and
patient per visit with the average number of visits per year reported in the patient exit
interviews. There was less of a difference between the ISPA and nurse pharmaceutical
care models; this is partly because the high cost to the provider in the nurse model is













Cost of ART service use, compared between different levels of service
Level of service Cost to
provider
Cost to patient Societal costAverage
number of
patient visits












7.78 $6.55 $10.04 $16.58 $128.99
ISPA 10.74 $5.74 $7.44 $13.18 $141.55
Nurse 9.78 $10.16 $6.29 $16.45 $160.89
While the annual cost per patient for the pharmacist model is lower than for the ISPA
model, the average cost per visit is higher. This relates to the difference in the average
number of patient visits per year. Patients who are stable and adherent on treatment
are given enough medication for two months and would therefore, on average, only
visit the facility six times per annum. Given that the pharmacist model at more
centralised facilities, has been available for longer, their patients have been on
treatment longer (see Table 2) and are therefore more likely to visit the clinic less
often. This decreases the burden of care on the clinic and more patients can be seen
using similar resources, while minimising the cost to the patient.
The cost of upgrading a medicine room to a dispensary
While the ISPA model is the cost saving option to the provider, there is an
infrastructure upgrade required when moving from the nurse- to the ISPA model. For
the nurse model there is no need for a pharmacy or dispensary as medication is
prepared for the patient at a central dispensary and merely handed out by the nurse in
patient ready packs. However, the ISPA model requires a dispensary to be registered
with the South African Pharmacy Council (SAPC). A case study from the district
sampled was selected and expenditure costs obtained to provide an idea of the
approximate costs of an upgrade (Table 5).
A total cost of $11 479.88 was spent in the upgrading of the facility. In the case study,
the cost for the upgrade was paid for by a non-governmental organisation and the











included enlarging of the medicine room, the installation of concrete beams in the
room to improve security, installation of a security gate, shelving and the purchasing
of a vaccine refrigerator as well as a backup household fridge.
Table 5
The cost of upgrading a medicine room to a dispensary
Description Cost (Rand)
The modification and enlarging of











Data sources: Lizette Monteith, Keth'Impilo; Lindsay Wilson, PGWC
HIV directorate and Margaret von Zeil, City of Cape Town
Sensitivity analysis
A sensitivity analysis was conducted to test what the impact on the results would be if
one were to vary some of the assumptions. Key assumptions that could detract from
the robustness of the results include variations in the time spent by nurses on
dispensing-related activities, as well as the number of clinic visits per year. Both of
these assumptions are likely to differ depending on the facility and particular
characteristics of the service provided. In the sensitivity analysis, the baseline
represents the current practice at the facilities, where the amount of time nurses spend
on dispensing related activities was observed and averages about 60% of their time. A
"best case" scenario was considered, where it was assumed that nurses were not
involved in dispensing activities at all in the pharmacist and ISPA models and at the
observed average of 60% of their time in the nurse model. This scenario also assumed
that visits occurred every two months. The ratio of the cost for the ISPA to nurse
models was similar for the baseline scenario (see Table 6). A “worst case” scenario











related activities, which was based on the maximum time estimated by nurses
interviewed. This scenario also assumed that patients attended the clinic monthly. For
scenario 2, the original results held and the ISPA model was still less costly than the
nurse model”
Table 6
Sensitivity analyses of provider costs
Assumptions Outcomes






















One pharmacist and one
































The results of the cost analysis suggest that while both of the decentralized
approaches, the ISPA- and nurse-driven pharmaceutical care models, significantly
decreases direct and indirect costs to patients when accessing treatment, the ISPA
model once implemented would also be the least costly to the provider per patient
visit (see Table 4). However, only considering the costs does not give us the full











During the patient exit interviews, respondents were also questioned about whether
they would prefer to receive their medication from the nurse or from the pharmacy.
The response was most surprising from facilities where the ISPA model had already
been implemented. At these facilities, the ISPA model had provided an opportunity
for the integration of HIV and other chronic diseases management with all patients
receiving medication from the same pharmacy in the facility and waiting in the same
waiting room. However, the majority of respondents from these facilities indicated
that they would prefer to receive their medication directly from the nurses. Here are
some of their responses:
“I have to walk past people to get the pharmacy and they might recognise me. Also
for the time saved” (Respondent, Pharm clinic 2)
“The people ask us so many questions that are not pleasant. I don’t find it easy to
collect them [her medication] at the pharmacy ‘coz it is like automatic disclosure of
my status to everyone” (Respondent, ISPA clinic 1)
Many of the responses reflected a spatial component to the stigma of HIV, related to
being identified when seen by other community members collecting medication
(visually known as ART) from the pharmacy. At one of the ISPA model facilities, the
identification of people who are HIV positive was facilitated by the use of a different
coloured folder for those who are not on ART.
The fear of stigma and the value of anonymity also played a central role in patients’
choice of health facility. As some explained:
“I feel safer here; the people do not know me here. [It] would’ve been cheaper to go
to [facility name] but [I] still rather come here.” (Respondent, Pharm clinic 1)
“There are too many people in [facility name] and a lot of people there talk badly











“My child gets ARV’s from [facility name] but I don’t like it there. There are a lot of
people there. If you go that side everyone knows you are positive. Here [current
facility] we are not separate.” (Respondent, Nurse clinic 1)
While respondents preferred receiving their medication directly from the nurse as
opposed to the pharmacy as they felt that their anonymity was protected, there was a
trade-off. A challenge of the nurse-driven pharmaceutical care model revolved around
the logistics of ordering medication for each patient based on their latest prescription
in advance of their appointment, and that patients sometimes arrived out of
appointment dates, requesting medication. In an attempt to ensure that patient care
continues, nurses would then open the pre-packed medication and dispense
medication to patients from that source. This is how respondents described it:
“They give you “bietjie bietjie” [little, little] tablets with other people’s names on. It
confuses us.” (Respondent, Nurse clinic 2)
“Last month I came and they gave me treatment for another person. Even now they
gave me treatment for a week and it’s not in my name.” (Respondent, Nurse clinic 2)
“I don’t like the fact that I would come on my date and leave the clinic without getting
my pills, I have to take time away from work and my boss is not happy with it.”
(Respondent, Nurse clinic 2)
At one of the facilities, there were also concerns that medication ordered but not
collected, were stored in a drawer. This left the stock open to be stolen, and is not
stored in the correct conditions and could compromise patient safety.
Discussion
Each of the pharmaceutical care models has a unique set of benefits and challenges, as
summarised in Table 7. Health services are provided in a team, and an inappropriate
mix of staff can be inefficient and limit patient’s ability to get the treatment that they
need. The full-time pharmacist model is presented as the standard of care that would












Comparison of Pharmaceutical Care models
Pharmaceutical care
provider
Full-time Pharmacist available Pharmacists Assistant under indirect supervision Nurse-led service provision
Overview
Full-time pharmacist dispensing medication from a
prescription written by doctor, directly to the patient.
The PA works under the indirect supervision of an
offsite pharmacist who conducts monthly visits and
provides telephonic support.
Dispenses directly to patients from a legal prescription
written by a doctor.
Responsible for stock control.
One pharmacist is allowed to supervise up to 5
pharmacists’ assistants.
This service is often provided in conjunction with an
outreach service from a larger centre or in small
satellite clinics.  Medication is pre-packed by a
pharmacist for each patient (patient-ready packs) and
delivered to the clinic from which the nurse hands out
the medication and monitors the patients’ condition.
Requirements
Service is available at larger facilities, for example at a
community health centre. Dispensing is conducted
from a pharmacy, operated under the personal
supervision of a responsible pharmacist, licensed by
the DOH and recorded with SAPC.
Dispensary has to be secure, organised, temperature
controlled. Pharmaceuticals and related products are
ordered, stored and dispensed directly to clients by the
PA and issued to staff for treatment areas. Dispensary
design and layout is similar to that of a pharmacy but
with smaller floor size.
Storage of medication in a medicine room. The
medicine room is intended as a secure, organised,
temperature controlled room with limited access, for
the bulk storage of pharmaceuticals, for refilling
trolleys or cupboards in treatment rooms.
No direct patient dispensing, only from patient-ready
packs or according to standard operating procedures.
Highly skilled and trained health professional,
experienced in working under pressure and in a team.
More cost-effective in salary and training costs [10] Increases access to ART for patient
Promote rational prescribing and is therefore cost-
saving
Onsite to assist in stock management and if patient
comes outside of appointment dates.
Patients have established rapport with clinician
Benefits
Increases access to ART There is a perception of time saved if clinician
dispenses, though each consultation will take longer.
Scarce Insufficient training (operational management, dealing
with the public/ providers)
Prescriber and dispenser is the same person – potential
for mistakes.
Would limit scale-up of ART service Does not have the authority/ skill to promote rational
prescribing.
Nurses might not be aware of drug interactions
between drug classes.
Expensive training Limited pharmacology training Service is likely to reach saturation point sooner.Problems











and therefore been cost saving [52]. However, with the shortage of pharmacists, and
an expensive 4 year training program, this approach would limit the scale-up of ART
service provision. The benefits of the ISPA model are that pharmacists assistants
undergo only a 2 year in-service training course supervised by a pharmacist. The PA
dispenses directly to the patient and is responsible for stock control. In terms of
supervision, one pharmacist can supervise up to five PAs simultaneously. Some
concerns are that a PA might not be getting sufficient training, they have limited
pharmacology training and do not have the authority to promote rational prescribing.
Osman (2005) makes the point that PAs also lack a career path.
The nurse model is very useful in that it provides an option for the rapid scale-up of
ART services, although it also reaches saturation point sooner due to the difficulties
of ordering medication per patient appointment. Medication is not dispensed directly
to patients but only from patient-ready packs with the help of standard operating
procedures. While there is a perception that waiting time will be reduced when nurses
dispense medication, it is more likely that consultation times will be longer and
waiting times will increase.
Where there was a lack of doctors to renew prescriptions, this also resulted in
increased waiting times and more time spent by nurses being involved in the
dispensing process. While nurse prescribing and dispensing was not a model
evaluated in this study, it has been proposed and might conceivably decrease waiting
times. However, it does raise concerns when the prescriber and dispenser is the same
person, as there is a lack of quality control.
The generalisability of this single district evaluation could be seen as a limiting factor
given that the functioning of a facility is dependent on many facility-specific
characteristics such as the level of skilled staff, skill mix, the infrastructure available
and staff motivation [53]. More specifically, the role(s) of staff members in
pharmaceutical care could be considered as endogenous to the broader arrangement of
HRH within these facilities and may partly account for variations within these
models. However, the study does provide a framework within which to evaluate other
facilities and some experiences will be common to many facilities. An additional











such as the importance of the different colour folders and influence on patients access
to treatment. Further research to explore health professionals’ opinions is
recommended.
Conclusions
In reality, these pharmaceutical care models are not mutually exclusive options and a
variety of systems will no doubt be required to achieve scale-up. While the ISPA
model is the least costly to the provider and to the patient, the concerns of patients in
terms of confidentiality and the avoidance of stigma needs to be addressed as it could
negatively impact on patients’ health seeking behaviour. In contrast, the nurse-driven
pharmaceutical care model is useful in rapidly scaling-up pharmaceutical care and
indeed rolling-out ART service provision to new sites as capital outlay and the
recruitment of dispensing personnel is not needed. It does however place a burden on
nurses, uses more costly staff and reports suggest that pharmaceutical care may be
compromised with patients needing to return to the health facility out of scheduled
appointments to collect medication due to them. Both of these pharmaceutical care
models have a place in service provision, but it is imperative to address quality of care
and confidentiality concerns from patients. This could be achieved by removing ART
service identifiers from patient folders, by putting up screens next to the pharmacy
dispensing window to limit the view from the waiting area, and dispensing all
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Part D: Policy brief
The impact of pharmaceutical care models on access to
antiretroviral therapy
Summary
Two alternative pharmaceutical care models, dispensing by a nurse and by a pharmacists assistant were
compared against the standard practice of pharmacist dispensing. The models were evaluated on the
basis of cost from the health service perspective as well as patients’ access to antiretroviral treatment
(ART). The task-shifting models were shown to improve patients’ geographical and financial access to
treatment through lower travel costs. The results further suggested that while the pharmacists assistant
model was less costly than the nurse-driven model and would strengthen and support a more integrated
primary health care service, patients preferred receiving their medication directly from the nurse. The
reasons related to trust and the fear of stigma. Measures to improve patient confidentiality when
receiving medication from the pharmacy, such as removing ART service identifiers from patient
folders, and dispensing all medication in brown paper bags, is likely to positively impact on patients’
access to ART.
Introduction
This policy brief discusses results from a study conducted in the Western Cape,
evaluating different models for the dispensing of antiretroviral treatment (ART) and
their impact on patients’ access to healthcare. The burden of need for ART and the
resultant need for the decentralisation and integration of ART services into the
primary health care system is well documented.  This will require a scale-up of
pharmacy services in terms of supply systems, infrastructure and staff to ensure a safe
and efficient pharmaceutical service within an environment of scarce Human
Resources for Health (HRH).
Models of pharmaceutical care
Task-shifting has been shown to be an effective and safe option for addressing the











tasks from highly skilled workers to those with either less training or task specific
training. In South Africa, the shortage of pharmacists in the public sector has led to
the use of Pharmacists Assistants (PA) and nurses to support the expansion of the
ART programme. Different models of pharmaceutical care have been used, and
include variations of:
 Pharmacist model (the standard of care) where medication is dispensed by a
pharmacist directly to patients.
 Indirectly supervised pharmacists assistant (ISPA) model where a PA working
under the indirect supervision of an offsite pharmacist, dispenses medication
directly to patients and is responsible for stock control.
 Nurse model where prescriptions are sent to a nearby hospital pharmacy, where
they are prepared before the patient’s expected appointment date and delivered to
the primary health care clinic in patient-ready packs. The nurse then provides the
patient with medication, reviews the patient’s progress, and returns uncollected
medication to the pharmacy.
How were the different pharmaceutical care models evaluated?
The study was conducted in a peri-urban district in the Western Cape of South Africa.
Within the district, six health facilities were sampled based on the model of
pharmaceutical care used. A total of 224 patient exit interviews were conducted,
patients’ waiting times were documented and staff time spent on pharmacy related
tasks were observed. In order to get a complete picture of which model is most
appropriate, the cost implications for the health system was calculated and the impact
of the service offered on patients’ access to health care was assessed.
Is it an efficient use of nurses’ time to dispense medication?
The aim of economic evaluations is to highlight the differences in cost between health
care interventions, and to compare it with a gain or loss in outputs. The primary cost
differences between the pharmaceutical care models relates to the staff providing the












Staff cost of ART service use, compared between different service models
Level of service Average number of visits per
patient per  year





Full-time pharmacist 7.78 R 50.78 R 395.07
Pharm assistant under
indirect supervision
10.74 R 44.76 R 480.72
Nurse-driven
dispensing
9.78 R 79.26 R 775.16
While from the results in Table 1 it seems as if the least expensive model would be to
have a pharmacist driven service. This is partly due to economies of scale, whereby in
the pharmacist model more patients can be helped by a pharmacist working with
pharmacists assistants. As well as due to fewer visits per annum in the pharmacist
model because the service has been running for longer, patients are more stable on
treatment and are therefore receiving their medication every two months as opposed
to monthly. The scale-up of a pharmacist driven service is not necessarily an option
given the scarcity of pharmacists and the impact of a centralised pharmacist driven
pharmaceutical care model on patients’ access to treatment. The results further
indicate that between the task-shifting models, the ISPA model is less costly to the
service provider per patient visit. In fact, the costs per visit for the nurse model is
almost double that of the ISPA model. This relates to the value of nurses’ time, and it
is important to consider whether it is an efficient use of nurses’ time to dispense
medication.
What is the cost of upgrading a medicine room?
An additional cost that comes with the implementation of the ISPA model is that it
requires a dispensary registered with the South African Pharmacy Council. Smaller
primary health care clinics often only have a medicine room designed for the bulk
storage of patient-ready packs for the refilling of trolleys or a cupboard in treatment
rooms. The medicine room is often not big enough to support the dispensing of
products directly to patients. An estimate of the cost of the infrastructure upgrade is












The cost of upgrading a medicine room to a dispensary
Description Cost (Rand)
The modification and enlargement
of medicine room to dispensary
R 18 737.00
Security R 8 500.00
Equipment
Shelving R 8 874.64
Signage R 85.00
Electronic & electrical R 42 617.00
Reference sources R 1 297.50
Dispensing equipment R 6 296.57
General R 3 135.34
Total R 89 543.05
Data sources: Lizette Monteith, Keth'Impilo; Lindsay
Wilson, PGWC HIV directorate and Margaret von Zeil,
City of Cape Town
The costs were sourced from expenditure documents related to a facility in the district
studied which had recently invested in this infrastructure.  The upgrade of the
medicine room does not only benefit the ART service but it enables the dispensing of
medication for other chronic and acute conditions treated in the health facility, which
supports a more integrated and holistic approach to health services.
How do decentralised care models affect patient access to care?
Availability
More patients lived within walking distance of the ISPA (95%) and nurse model
(87%) facilities than those attending pharmacist model facilities (28%), and patients
attending the pharmacist model facilities spent more time travelling.
In spite of the greater geographical availability of the service, patients attending the
ISPA and nurse model facilities did not always have access to ART. Drug stock-












 At the ISPA facility, 30% of respondents indicated that they did not always
receive medication and had to return another day to collect medication due to
them. This is compared to 42% of respondents at the nurse clinic.
 The reasons for drug stock-outs are related to difficulties in stock management. At
the nurse clinic, patients did not always arrive on their appointment dates, or their
prescriptions changed and in order to facilitate care, the nurse would give some
medicine prepared for another patient. This resulted in a cycle of insufficient drug
supply and was concerning for patients:
“They give you ‘bietjie bietjie’ [little little] tablets with other people’s names on it.
It confuses us.” (Respondent, Nurse clinic 2)
“I don’t like the fact that I would come on my date and leave the clinic without getting
my pills, I have to take time away from work and my boss is not happy with it.”
(Respondent, Nurse clinic 2)
 At the ISPA facility, drug stock-outs related to the impact of insufficient doctors
at the facility to renew prescriptions and resulted in the PA being unable to
dispense medication for patients.
Affordability
Multiple visits to the clinic due to drug unavailability have cost implications and
could impact on sustained adherence to ART. Patients incurred significant costs in
attending ART services amounting to an average of R37.18 per visit by patients
attending a pharmacist clinic, compared to R12.60 per visits at an ISPA clinic and
R16.03 at a nurse-based clinic. Respondents who were employed said that they
forfeited an average of approximately R100 per day in missed wages.
Acceptability
In spite of the challenges regarding stock management in the nurse model, the
majority of respondents indicated that they would prefer receiving medication from
the nurse as opposed to at the pharmacy. While there was an element of hope that











for preferring nurse-based dispensing related to trust in confidentiality being
maintained. Respondents preferred nurse dispensing in an effort to avoid stigma.
“The people ask us so many questions that are not pleasant. I don’t find it easy to
collect them at the pharmacy ‘cause it is like automatic disclosure of my status to
everyone.” (Respondent, ISPA clinic 1)
“At the pharmacy there is also a person from my neighbourhood and they’ll ask and
wonder why I collect this medication.” (Respondent, Pharm clinic 1)
In addition, respondents at one of the ISPA facilities explained that different coloured
folders are used for patients in the ART program than what is used for the patients
accessing other services at that facility. The respondents likened having to wait at the
pharmacy with these folders to “automatic disclosure”.
“The queue is very long at the chemist and with us ARV clients our folders are
different from other people so they can easily see that we are HIV positive”
(Respondent, ISPA clinic 1)
“People say things about us because we have different folders, so if they can change
the folder maybe it would be fine to take treatment at the pharmacy”
(Respondent, ISPA clinic 1)
Key issues
 The task-shifting pharmaceutical care model facilities facilitated geographical
access to care with more patients being able to walk to the clinic.
 Given the scarcity of pharmacists, the ISPA model is a less costly option than the
nurse-driven model in terms of staff costs.
 Both task-shifting models experienced challenges in drug stock management.
 Patients prefer receiving their medication from nurses, in order to avoid the stigma












The study highlighted that while the ISPA pharmaceutical care model is cost-saving
when compared to the nurse model, more efficient in terms of the use of nurses’ time,
and supports the integration of ART services into primary health care, it is important
to address patients’ concerns around confidentiality and stigma.
Possible approaches would be to:
 Remove any ART service identifiers from patient folders by ensuring that all
patients accessing the facility have the same colour and type of folder,
 Improve patient confidentiality at the pharmacy window by putting up screens
next to the window, limiting the view from the waiting area, and dispensing all
medication (not just ARTs) into brown paper bags.
The research presented in this paper was conducted by Nicola Foster and funded by the National





















ECONOMIC EVALUATION OF TASK SIDFTING APPROACHES TO THE 
DISPENSING OF ANTI-RETROVIRAL (ARV) TREATMENT 
RESEARCH INFORMATION SHEET 
You have been asked to participate in a research study that is being conducted as part of a Masters 
degree in Public Health from the University of Cape Town (VCl). Before you agree to participate, 
I would like you to understand why this research is being done, and what I will be asking of you as 
a participant. 
Why is this research being done? 
In South Africa we have a shortage of doctors, nurses and pharmacists. This shortage affects our 
ability to provide good quality health care for everyone within his or her local community. We are 
looking for ways in which to make the health service more efficient by perhaps training more 
people to do jobs that would originally have been done by pharmacists or nurses so that the 
pharmacists! nurses would be able to do the work that they are especially good at. In this study we 
are trying to find out what the costs and the benefits would be of using pharmacist assistants to 
provide people with their ARVs as opposed to the nurse, doctor or pharmacist providing the 
medicine at the moment. 
What information will be collected and how? 
In order to find out how much time you spend waiting at the clinic and where, you will be given a 
piece of paper on which the health workers will record when you arrive at a certain service and 
when you leave. The paper is to be given back to me before your interview. 
After you have been helped, we would like to ask you some questions on how you get to the 
clinic, possible costs involved for you in being at the clinic as well as questions regarding how 
often you take your medicine. These questions will be asked in the form of an interview in a 
private room. The interviewer will record your answers, but your name will not be used in the 
reporting of the results. 
The questionnaire is three pages long and should take no more than 15 minutes to complete. 
What are the benefits of participation? 
You will receive no personal benefits to participation in the study. However, this research could in 
the future benefit your community by changing the way in which health services are delivered. 
What are the harms! risks to you in participating? 
There are no foreseen physical harms to your participation in the study, but to protect your 
anonymity while participating in this study the interview will be conducted in a private room. 
Please note that non-participation in the study will in no way have an effect on your current or 










The Consent Form will further explain your rights and responsibilities while participating in the 
research. The fieldworker will read and explain the consent form to you and if you are willing to 
participate, we will ask to sign that you agree to participate. You are welcome to take this 
information form home with you, so that if you later have any questions regarding this research 
you are welcome to contact me. 
Contacts 
Nicola Foster 
Researcher: Masters student (VCT) 
Professor Diane McIntyre 
Supervisor (VCT) 
Tel: 079 773 5288 
e-mail: Nicola.Foster@uct.ac.za 
Tel: 021 406 6579 
e-mail: Diane.McIntvre@uct.ac.za 
Questions or concerns for the VCT research ethics committee can be referred to: 











ECONOMIC EVALUATION OF TASK SmFTING APPROACHES TO THE 
DISPENSING OF ANTI-RETROVIRAL (ARV) TREATMENT 
PATIENT EXIT INTERVIEW CONSENT FORM 
CONSENT TO PARTICIPATE IN THE INTERVIEW 
Facility: [enter name offacility] ___________________ _ 
I HAVE BEEN INFORMED ABOUT THE PROJECT ECONOMIC EVALUATION OF 
TASK SHIFTING APPROACHES TO THE DISPENSING OF ANTI-RETROVIRAL (ARJ? 
TREATMENT, AND I UNDERSTAND THAT IT IS UP TO ME WHETHER OR NOT TO 
BE INTERVIEWED. 
I understand that there will be no consequences of any kind through my participation (or non-
participation) in this study; in particular, there will be no impact on the care that I receive in this 
hospital! clinic or any other hospital! clinic. 
I understand that I can ask the person interviewing me to stop the interview at any time. 
I understand that the information that I give will be treated in the strictest confidence and that my 
name will not be used when the interviews are analysed. 
Yes, I give my permission for the interview. 
Interviewee's name (please print) 
Interviewee's signature Date 
Study sticker Place sticker here 
Interviewer's name (please print) 











ECONOMIC EVALUATION OF TASK SIllFTING APPROACHES TO THE 
DISPENSING OF ANTI-RETROVIRAL (ARY) TREATMENT 
PATIENT EXIT INTERVIEW QUESTIONNAIRE 
0.1 Date of interview dd I mm I yyyy 
0.2 Interviewer name 
0.3 Study sticker Place sticker here 
0.4 Start time of interview hour min ---- ----
0.5 Site (name offacility) 
Instructions for interviewers: 
arts of questions that do not always have to be read out and instructions 
are in ==.,.ted te . 
Unless specifically asked to do so, options do not ne d to be read out but should 
rather be used as a guide and as prompts to illicit a response from respondents. 
Skips indicating which questions can be left out are represented by arrows 




1.2 What was your age at 
your last birthday? Yearbom Years 
SECTION TWO: UTILISATION AND ADHERENCE 
When did you FIRST begin 
2.1 receiving anti-retroviral (ARY) 
Mm Yyyy treatment? 
Monthly or less 
How often do you collect your (weeklylbi-weekly) 
2.2 ARV treatment here at the Two-monthly 
clinic? More than two-
monthly 
Besides ARVs, are you able to Yes 
2.3 get the other health services you 
need in this facility? 
No 







1 If YES, 












Did you miss taking any of your ARV tablets Yes I 
YESTERDAY? No 0 
2.6 
Did you miss taking any ARV tablets the day Yes I 
before YESTERDAY? No 0 
2.7 
Did you miss taking any ARV tablets 3 DAYS Yes I 
ago? No 0 
2.8 
Apart from the last three days, have you ever Yes I 
missed taking any ARV tablets? No 0 
2.9 
Have you missed any VISITS to the ARV clinic Yes I 
HNOgo 
in the last 6 months? No 0 to 3.1 
2.10 
CD2. If YES, how many VISITS did you miss? 
no. of visits 2 
What was the reason( s) for missing the visits? 
Do not read the list aloud; probe respondent to 
Yes No give up to three reasons. Circle up to three yes 
options and circle all others no. 
Lack of money I 0 
Lack of time 1 0 
I felt better 1 0 
I could not take time off from work 1 0 
No transport I 0 
Too ill to travel 1 0 
2.11 
Other responsibilities 1 0 
The treatment does not make 
I 0 
me feel better 
The queues in the facility are too long 1 0 
The staff are rude or uncaring 1 0 
I have had bad experiences with 
I 0 
staff before 
Don't know 99 
Other 97 
If other, please specify 
SECTION THREE: AFFORDABILITY 
In coming to receive treatment today, how much 
3.1 
did you pay for: 
Rand 
Read out each item, if no money spent, code as 
"0" for each item. 
Transport (one way) 
Clinic/ hospital fees 
Medicines 
Someone to take over your tasks while you are 
here, including childcare 
Accommodation if you need to stay the night 
nearby 
Food during visit 











If other, please specify 
Did you find it easy or difficult to incur 
Easy I 
Difficult 2 
3.2 these expenses? 
Neither easy or difficult 98 (refer to expenses in 3.1) 
Don't know 99 
3.3 Are you currently employed Type of employment 
(working or earning money)? Yes, full-time I 
Yes, part-time 2 
If NO, go 
No 0 to 3.6 
Don't know 99 
3.4 
If YES, did you lose income from the time you Yes I 
took from your job to come here today? No 0 
3.5 If YES, how much money did you lose? 
(Rand) 
3.6 
Are there extra medicines you need that you are Yes I 
not receiving at the facility? No 0 If NO, go to 4.1 
If YES, which type of medicines are you buying and how much do 
Rand 
you spend per month? 
Pain medicine (Painblok®) 
Vitamins 
3.7 
Cream for itchy skin (Dovate®) 
Moisturising cream (Aqueous cream) 
Other 
If other, please specify 
Did you find it easy or difficult to 
Easy 1 
Difficult 2 
3.8 incur these expenses? 
Neither easy or difficult 98 (refer to expenses in 3.6) 
Don't know 99 
SECTION FOUR: AVAILABILITY 
4.1 Is this the closest clinic to your home that offers AR V treatment? 
Yes 1 If YES, 
No 0 20 to 4.3 
(f.Nd, why do you prefer this facility? 
4.2 
4.3 How did you get here today? Yes No 
By foot 1 0 
Bicycle I 0 
Minibus taxi I 0 
Bus/train 1 0 
Own private car I 0 
Other private car (meter taxi, hire car, catching a lift) I 0 
Ambulance/ hospital transport I 0 
Other 97 










4.4 How long did it take you to get to the 
clinic today? (one way only) Hours Minutes 
SECTION FIVE: ACCEPTABILITY 
READOUT 
Different people have different preferences in how and where they get their 
medicine, I would like to ask a few questions about what you prefer. 
5.1 




have you ever left without ARV tablets? No 0 
5.2 Have you ever had to come back another day (other than your Yes 1 
appointment date) to collect tablets owed to you? No 0 
At the clinic 1 
5.3 AD OUT: Where would you prefer Hospital 2 
to collect your ARV medicines? Indifferent 98 
Don't know 99 
Note: Insert the respondent's previous response into the questi n: 
Why do you prefer the ............. (clinic/ hospital)? 
5.4 
In receiving your ARV medicines, 
what would you prefer: DoctorlNurse 1 
(a) For the doctor/nurse to give 
5.5 you the medicine after seeing Pharmacist!assistant 2 
you; or to 
(b) Collect the medicine at the Indifferent 98 
facility's pharmacy from a 
pharmacist! assistant. Don't know 99 
Note: Insert the respondent's previous response into the question: 
Why do you prefer the ............. (doctor/nurse/pharmacist!assistant)? 
5.6 
Do you have anything else that you would like to tell us about your experience 
of seeking or receiving ARV care at this facility? 
5.7 
Note the end time of the 











ECONOMIC EVALUATION OF TASK SmFTING APPROACHES TO THE 
DISPENSING OF ANTI-RETROVIRAL (ARV) TREATMENT 
OBSERVATION TOOL 
Facility: 
Place sticker here 
Name offieldworker: 
Date 
I dd mm YVVV 
Time of entry of facility 
hour min 
NURSE (indicate if not applicable) Nt A 
Time of Entry 
I ' I 
Time of Exit 
I ' I hour min hour min 
DOCTOR (indicate if not applicable) Nt A 
Time of Entry 
I ' I 
Time of Exit 
I ' I hour min hour min 
PHARMACY (pharmacist! pharmacist-assistant) (indicate if not applicable) Nt A 
Time of Entry 
I ' I 
Time of Exit 
I ' I hour min hour min 
Time of exiting facility 
hour min 
ECONOMIC EVALUATION OF TASK SmFTING APPROACHES TO THE 
DISPENSING OF ANTI-RETROVIRAL (ARV) TREATMENT 
OBSERVATION TOOL 
Facility: 
Place sticker here 
Name offieldworker: 
Date I dd mm yyyy 
Time of entry of facility 
hour min 
NURSE (indicate if not applicable) Nt A 
Time of Entry 
I ' I 
Time of Exit 
I ' I hour min hour min 
DOCTOR (indicate if not applicable) Nt A 
Time of Entry 
I ' I 
Time of Exit 
I ' I hour min hour min 
PHARMACY (pharmacist! pharmacist-assistant) (indicate ifnot applicable) Nt A 
Time of Entry 
I ' I 
Time of Exit 
I ' I hour min hour min 
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Dr N Peer 
021483 6858 
Health Economics Unit 




Dear Ms N Foster 




RE: AN ECONOMIC EVALUATION Qf JASK§Hlrn~G APPROACHES TO THE Qts!Ri8NG Of ANU-REIROVIRAL 
TREATMENT IN THE CAPE \MN~LANDS plSIRlg 
Thank you for submitting your proposal to undertake the abov&mentloned stucty. We are pleased to inform vou that the 
department has sranled you appl'OVal for your researctritt the fOllowing facilities. Plene contact the fadllty managef:5 to 
a~ you with acces.s to the fadUdes: 
1. Te Newman hospital 





Kindly ensure that the following are adhered to: 
1. Arrareemenb COIn b. made with manisars, Pfovicllna that I'IOrmal activiti8:5 at requested fadlltles are not 
Inter!'\lpted. 
2. Re-searchers. in ac:cessina PfO\lind~ heahh fadlities, are exFW"~1'II C'O~nt to provi= the department witt! an 
electronic COP'! of the final report within six months of completion of rese:arch. This can be 51.lPmlnecl to the 
provincial Research Co-ordinator (be<!lthres@psw![.scw·z:!,), 
3. The reference nut1'lber above :ohould be quoted in <til Mure correspgnClence. 
We look forward to heatl~ from you. 
youn'i"~ 
ORJOJPI ? DEPUTY·OIRfCT ~ EAAl 
P;sge '10f2 Dorpsttaar " 
-~""" KMPSTAD eooo 
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Foral12lrtlcles that Indude InformatIon or dlnlcal photographs relating to IndMdual patients, written and signed consent from ei!lch 
patient to publish must also be ITIIIIlled or faxed to the edltorll!ll staff. The rTIIInuscr1pt should also Include II statement to this effect In 
the Acknowledgements section, as follows: "Written consent for publication WZIS obtained from the patient or their relatlve.ft 
Human ResOUlt:eS for Health supports initiatives to improve the perfonnanc:z and reporting ofdinical trials, part ofwhidl indudes 
prospective registering and numbering of trials. The Intemational Committee of Medical Journal Editors (ICMJE) definlls a dinical trial 
as any researctl study that prospectively assigns human subjects to one or more hllaittl reiatlld intllrventions to llvaluate thll effects 
on health outcomes. Authors of protocols or reports of such dlnlcal trill Is, where the primary purpose of the researctl Is to 
understllnd thll causes, development and effects of disease, or to Improve preventative, diagnostic orthenlpeutlc Interventions, 
must register their trial prior to submission In a suitable publldv om!sslble registry. Registries which meet the requirements of the 
~ Indudll WHO prlmaIY Registries . The trial n=glstratlon numbllr should be Indudlld as thlliast IInll of the abstrJu;t of the 
manysg1pt. 
Human Resout"a!s for Health also supports initiatives aimed at improving the reporting of biomedical research. Checklists have been 
developed for a number of study designs, Indudlng randomized controlled trials lCQNSORD, systematic reviews ~, meta-
analyses of observational studies ~, diagnostic accuracy studies cs:re.BW and quantatlve studies ~. We recommend 
authors refer to the ~ network website for further Infonnatlon on the available reporting guidelines for health researctl, and 
the MIBBI Portal for prescrlptlvll checklists for reporting biological and biomedical resllarch whllre appilcabill. Authors are re!qullsted 
to make USll ofthesll when drafting thllir manuscript and Pllllr revillwers will also bll asked to refer to thllse checklists when 
evaluating thllSll stud illS. For authors ofsystllmatic revillws, a supplementary file, linklld from thll Methods sllction, should 
reproduce all details conceming the search strategy. For an example of how a sllard'l strategy should be presented, see thll 
Cochrane Reviewers' Handbook. 
Authors from phannaceutlcal companies, or other commercial organizations that sponsor clinical trials, should adhere to the ~ 
Publication Practice guidelines fur pharmaceutical companies , which are designlld to llnsure that publications are! produced in a 
responsible and llthical mannllr. Thll guidlllinllS also apply to any companies or individuals that work on industry-sponsored 
publications, such as freelance writers, contract research organizations and comlTlJnications COmpanillS. 
The Involvement of medical writers or anyone else who assisted with the preparation of the manuscript content should be 
acknowledged, along with their source of funding, as desa1bed In the Eyrooean Medical Writers association (EMWAl gyldellnes on 
the role of medical writers In developing oeer-revlewed pybllcatlons If medical writers are not nsted among the authors, It 15 
important that their role be acknowledged explicitly. Wll SUggllSt wording such as 'We thank Jane Doll who providlld medical writing 
services on behalf of XYZ Pharmaceuticals Ud.'. 
Any 'In press' artldes cited within the references and necessary forthe reviewers' assessment of the manusa1pt should be madll 
avallablll If requested by thll editorial omce. 
Submission of a manuscript to Human Resoun:es forHeafth implies that readily reprodudble materials described in the manuscript, 
including all relevant raw data, will be freely available to any sdentist wishing to use them for non-commerdal purposes. Nudeic add 
sequllnces, protein sllquences, and atomiC coordinates should be deposited In an appropriate database In time for thll aa:esslon 
number to bll Included In the published article. In computational studies where the sequence Information Is unaa:eptable for 
Inclusion In databases because of lack of experimental validation, the sequences ITIJst be published as an additional "Ie with the 
article. 
Nucleotide sequences 
Nudeotlde sllqullnces can bll dllposlted with the pNA Pata Bilnk of Japan (DOW), Eyropean Molerular Blgiggy I abgratoIY (EMBIIEBIl 
Nl'degtlde Seguence Dltabase or ~ (National Cllnter for Biotechnology Infonnatlon). 
ProbIIn ",_neII. 
Protein sequences can bll dllposited with SwissProt or thll Protein Information Resource (PIR). 
Struc:tul'll. 
Protein structures can be deposited with one of the members of the Worldwide Protein Data Bank NudlllcAdds structures can be 
deposited with the NudelcAliid Database at Rutgers. Crystal structures of organic compounds can be deposited with the CarrPrldge 
Crvstallographic Data Centre . 
ChamICIII.truc:tuI'll •• nd • ....,. 
Structures of chemical substances can bll depositlld with PubChem SubstanC!!! Bioactivity saellns of chemical substances can bll 
deposited with PubChem BioAssay. 
Where appropriate, authors should adhere to the standards proposed by the Mlqparray Gene EXQresslgn pata Sgdflty and must 
deposit mlaoarray data In one of the public repositories, such as AlDyExpress Gene Expression Omnlbys (GEO) or the ~
Information Biology Gene Expression Datpbase (CIBEX). 
CDmputio1lll1 modeling 
We encourage authors to prepare modllis of biochemical reaction nlltworks using thll svst!!D1!i Blglggy Markup Langyage and to 
deposit the modlll with thll BIgMgdels database as wllil as submitting It as an additional flill with thll manuscript. 
PI •• mld. 
We encourage authors to dllPOSIt COpillS of their plasmlds as DNA or bacterial stocks with ~ a non-profit repository, or 
.eJu.mlI2, the Plasmid Infonnatlon Databasll at Harvard. 
BioMed Central is a member of the Committee on Publication Ethics (COPE). Authors who have appealed against a rejection but 
remain concemed about the editorial proC!!!ss can refer their case to COPE. For more information, visit www.publicationethics.org 
BIoMed Central llndorses thll World Assodatlon of Mlldlcal Editors (WAME) pgllQ! Statement po Gegpglltlqll Tntws!gn gn Edltgdal 
lll:<IiIl>nl. 
Preparing main manuscript text 
File format. 
The following word processor file formats are acceptablll fur the main manuscript document: 
return to top 
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Microsoft: Word (Yl!!rsion 2 and above) 
• Rich text format (RTF) 
• Portable document format (PDF) 
• TeX/LaTeX (use BlpMed Central's !eX template) 
• DeVice Independent format (OVI) 
• Publlcon Document (NB) 
Users or other word processing packages should save or convert their files to RTF befor1!l uploading. Many free tools are available 
which ease this process. 
TeX/LaTeX users: We recommend using BlgMed CentlJll's reX template and BlbTeX stylen!e If yoU use this standard tomat, you can 
submit your manuscript In TeXformat (aJteryou submit yourTEX file, you will be prompted to submit your BBL nle). If you have used 
another template for your manusa1pt, or If you do not wish to use BlbTeX, then please submit your manuscript as iii DVI "Ie. We do 
not recommend converting to RTF. 
Note that fI5I..!.u::ti. must be submitted lIS separate Image nles, not lIS part of the subrTtied DOC/ PDF/TEX/DVI "Ie. 
Article type. 





Please rud the descriptions of each of the article types, choose Which Is appropriate for your artlde and structure It accordingly. Ifln 
doubt,. your manuscript should be dasslned as Research, the structure for which Is described below. 
Manuscript sections for Re_arch articles 








• List of abbreviations used (If any) 
COrTl'eting interests 
Authors' contributions 
Authors' information (if any) 
Aclcnowledgements and Funding 
• References 
• Figure legends (If any) 
Tables and captions (If any) 
Description of addition III dllUl files (If any) 
You can downipad a templgte (compatible with Mac and Windows Word 97/98/2000/2003/2007) for your article. For instructions on 
use, see below . 
The AccllMlan Mum_1'II ofllny nucleic acid sequences, protein sequences or atomic coordinates cited In the manuscript should be 
provided, In square bl1llckets lind Indude the corresponding dlltllbll5e name; for example, [EMBL:AB026295, EMBL:AC137000, 
DDB1:AE000812, GenBank:U49845, PDB:1BFM, Swiss-Prot:Q96KQ7, PIR:S66116]. 
The databases for which we can provide direct links are: EMBL Nudeotlde Sequence Database CWDIJ, DNA Data Bank of Japan 
~}, GenBank at the NCBI ~, Protein Data BlInk cewn, Protein Infotmlltlon Resource CfIW and the Swiss-Prot Protein 
Database (Swiss-prot). 
Tille PllDil 
This should list the title of the article. The title should Include the study design, for example: 
A WI ........ in the treatment of C; • r.ndamized c:antrolled tri.1 
X I •• rI.k hlctDr for Y; • CII .. c:antrol .tudy 
The full names, institutional addresses, and e-mail addresses for all authors must be included on the title page. The corresponding 
author should also be indicated. _ct 
The abstract of the manuscript should not exceed 350 words and must be structured into separate sections: "'kground, the 
context and purpose of the study; ~., how the study was performed and statistical tests used; ..... b, the main findings; 
Cancl .. lan., briefsurTlTli!lry and potential implications. Please minimize the use of abbreviations and do not Cite references in the 
abstract; Tr1.II'IIIIII."'MIon, if your research article reports the results of a controlled health care intervention, please list your trial 
registry, along with the unique Identifying number, e.g. Tr .. 1 regilltr.tlan: Current Controlled TrIals ISRCTN73824458. Please note 
that there should be no space between the letters and numbers of your trial reglstli!ltlon number • 
•• ckgrouncI 
The badcground section should be written from the standpOint of researchers without specialist knowledge In that area and must 
dearly state - and, If helpful, Illustrate - the background to the research and Its alms. Reports of clinical research should, where 
appropriate, Include a summary of a search of the literature to Indicate why this study was necessary and what It aimed to 
contribute to the neld. The section should end with a very brlefstl!ltement ofwhl!lt Is being reported In the article. 
_ods 
This should Include the design of the study, the setting, the type of participants or materials Involved, a clear description of all 
Interventions and corTl'arlsons, and the type of analysis used, Including a power calculation If appropriate. 
"'un. .nd DI.a..lan 
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The Results and DisQJssion may be combined into iii single section or presented separately. Results of statistical analysis should 
include, where appropriate, relative and absolute risks or risk reductions, and confidence intervals. The results Clnd disaJssion 
sections may also be broken into subsections with short, informative headings. 
This should state dearty the main ClJncluslons of the research and give a dear explanation of their Importance and relevance. 
Summary illustrations may be induded. 
If abbreviations are used In the text, either they should be denned In the text where nrst used, or a list of abbreviations can be 
provkled, whldl should precede the competing Interests and authors' contrtbutlons. 
Competing inte ..... 
A c:cmpetlng Interest exists when your Interpretation of dete or presentlltlon oflnfonnlltlon may be Innuenced by your personal or 
nnancllli relationship with other people or organlzlltlons. Authors should disclose any flnllndlll competing Interests but 11150 any non-
financial CXImpeting interests that may cause them embal'1'8ssment were they to become public after the publication of the 
manusaipt. 
Authors lire required to complete II declaration of competing interests. All competing interests that are dedared will be listed at the 
end of published IIrtldes. Where an author gives no competing Interests, the listing will relld 'The lIuthor(s) dedllre that they hllve 
no competing Interests'. 
When completing your dedaration, please consider the following questions: 
Ffnanclal competing Interests 
In the past fIVe years have you received reimbursements, fees, funding, or salary from an organization that may in any way 
gain or lose financially from the publication of this manusaipt, either now or in the future? 15 such an organization finandng 
this manuscr1pt (Including the article-processing marge)? Ifso, please spedl'y . 
• Do you hold any stocks or shares In an organization that may In any way gain or lose ftnandally from the publication of this 
manusalpt, either now or In the future? If so, please spedfy. 
Do you hold or are you currently applying for any patents relating to the content of the manuscr1pt? Have you received 
reimbursements, fees, funding, orsalary from an organization that holds or has applied for patents relating to the content of 
the manusC'lpt? If so, please specify. 
Do you have any otherfinandal competing interests? If 50, please specify. 
Non-finandal competing Interests 
Are there any non-nnllndal cofT1)etlng Interests (political, personlll, religious, Ideological, llcademlc, Intellectual, commercllli or any 
other) to dedare in relation to this manuscript? If so, please specify. 
If you are unsure as to whether you or one of your co-authors has a competing Interest, please discuss It with the editorial ofnce. 
Author'll' conb'lbullorw 
In order to give appropriate a-edit to eam author of a papllr, the individual contributions of authors to the manuscript should bll 
spedfied in this section. 
An "author" Is generally considered to bll someonll who has made substantive Intellectual contr1butlons to a published study. To 
qualify as an author one should 1) have made substantial CXIntributlons to conception and design, or acquisition of data, or analysis 
and Interpretation of data; 2} have been Involved In drafting the manusaipt or revising It crttlcally for Important Intellectual CXIntenti 
and 3) have given final approval ofthll version to bll published. Eam author should have participatlld suffiCiently in thll work to take 
public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or gllnllral supllrvision of the 
resllarch group, alone, does not justify authorship. 
We suggest the following kind of format (please use initials to refer to eam author's CXIntribution): AB carried out the molecular 
genetic studies, participated in the sequence alignment and drafted the manuscript.1'f carried out the immunoassays. MT 
partidpated in the sequence alignment. ES participated in the design of the study and performed the statistical analysis. FG 
conceived of the study, and participated in its dllsign and coordination and hlllplld to draft the manuscript. All authors read and 
approved thll final manuscript. 
All contributors who do not meet the C'lteria for authorship should be listed In an acknowledgements section. ExafT1)les of those 
who might be acknowledged indude a person who provided purely temnical help, writing assistance, or a department chair who 
provided only general support. 
Author'll' Infarlnlltlon 
You may choose to use this sllctlon to Indudll any relevant InfolTT'l2ltlon about thll author(s) that rTII!Iy aid the reader's Intllrpretlltlon 
of the artlde, and undllrstand thll standpoint of the author(s}. This may Include dlltalls about thll authors' quallncatlons, current 
positions they hold at institutions or societies, or any other relevant background infonnation. Please refer to authors using their 
initials. Note this section shoukl not be used to desC'ibe any competing interests. 
Adcnowledgllll'lllMa .nd Funding 
Please IIcknowledge anyone who ccntr1buted toWllrdS the study by making substllntllli contr1butlons to conception, design, 
IIcqulsltlon of dlltll, or IInlllysls lind Interpretation of data, or who WillS Involved In drllfUng the mllnuscr1pt or revising It altlcally for 
important intellectual content, but who does not meet the aiteria for authorship. Pleasll also indude their source(s) offunding. 
Pleasll also acknowledge anyone who contributed materials essential for the study. 
The role of II medical writer must be Included In the IIdmowledgements section, Including their source(s) of funding. 
Authors should obtain pennission to acknowledge from all those mentionlld in the Admowledgllments. 
Please list the source(s) of funding for the study, for each lIuthor, and for the manusC'lpt preparation In thll acknowledgements 
section. Authors must describe the role of the funding body, If IIny, In study design; In the collection, analysis, and Interpretlltlon of 
data; In the writing of the manuscript; and In the dedslon to submit the manuscript for publication • 
.. r.rIIl'II:a. 
All references must be numbered conseQJtlvely, In square brackets, In the on:lllr In whim thllY are dted In the text, followed by any 
In tables or legends. Reference citations should not appeillr In titles or headings. Each reference m.Jst have an Individual reference 
number. Please avoid excessive referendng. If autolTBtlc nurmering systems are used, the reference numbers must be finalized and 
the bibliography must be fully fonnatted before submission. 
Only artides and abstracts that have been published or an!! in Pn!!ss, or an!! available through public ll-print/pn!!print Sllrvers, may bll 
db!d; unpublished abstracts, unpublished data and personal communications shoukl not be induded in the n!!fen!!nce list, but may 
be Included In the text and referred to as 'unpubllshed data', "unpublished observations', or "personal comm.lnlc:atlons· gMng the 
names of the Involved researchers. Notes/footnotes are not allowed. Obtaining permission to quote personal communications and 
unpublished data from the cited author(s) Is the responsibility of the ilIuthor. Journal abbreviations follow Index MedlcusjMEDUNE. 
CitZltions in the reference list should contain all nllmed 8uthors, regardless of how many there are. 
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Examples of the Human Resources fbrHeafth reference style are shown below. Please take care to follow the reference style 
precisely; references not in the corred: style may be retyped, necessitating tedious proofreading. 
Un .. 
Web links and URLs shoukl be Included In the reference list. They should be provided In full, Including both the title of the site and 
the URL, In the following format: 11.- Mo ... Tumor BIDIogy D •• tIII .. [http://tumor.lnfonnatIcsJax.org/mtbwl/lndex.do] 
Human R.esoIllWS for HHIth .......... nc. style 
Style Hies lire IIvllllllble for use with popular bibliographic IT12IInagernent son:ware: 
B"bTeX 
FndNgte §tyle file 
Reference Manager 
ArtIcle wlr:hln II joumal 
1. Koonin EV, Altsdlul SF, Bork P: BReAl proWln products: fwIctIonllllllDltfs. Nat Genet 1996, 13:266-267. 
Article within II joumiJIsuppiement 
2. Orengo CAr 6rily lE, Hubbard T, loConte L, Slliltoe I: AnIIly .... nd • __ rr.nt or.b Initio th .... -dime ... oRIII predctlon,. 
Mcondllry mucbre,.nd conblc:ts prediction. Proteins 1999, 43(SuppI3):149-170. 
In press article 
3. Kharltonov SA, Barnes PJ: CllnICIII ..... cm or mm.leeI nitric DXlde. EurRespir 1, In press. 
Published abstriKt 
4. Zvaifler NJ, Burger JA, Marinova-Mutaf'd1ieva L, Taylor P, Maini RN: M ... nchy .... 1 cells. strolNll derived "ctor-l .nd rheumatoid 
.rlhrltl. [ ....... ct]. ArthI1tIs Rheum 1999,42:5250. 
MIele within conference proceedings 
5. Jones X: zeolitet: end .ynti1etic mech8ni.lI18. In Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996i 
Baltimore. Edited by Smith Y. Stoneham: Butterworth-Hllinemann; 1996:16-27. 
Book chapter, or artk:le within II book 
6. Schnllpf E: From PNY YI. enda.ymblont to pI.8tld.: collllNlretlvll 8tudle.ln dlnot'legell .... In OrfgIns of PlllstJds. Volumll2. 2nd 
lldltlon. Edltlld by l.llwln RA. NllW York: Chapman and Hall; 1993:53-76. 
Whole IsSUll of journal 
7. Ponder B, Johnston 5, Chodosh L (Eds): [nnovetfve oncology. In 8iastClJncer Res 1998, 10:1-72. 
Whole conti!rence ~ngs 
8. Smith V (Ed): PrDcst!dings of the First National conference on PDmus Sieves: 27-30 June 1996i Baltimore. Stonllham: Butterworth-
Heinemann; 1996. 
Complete book 
9. MarguliS L: Origin ofEukaryotic O!Hs. New Haven: Vale University Press; 1970. 
MonognJpI! or book In a series 
10. Hunningh8ke 00, G8dek JE: 11-. .1v_I.r .... croph.ge.ln OJltured Human Cells and TISsues. Edited by Harris TIR. NllW Vork: 
Ac:adllrric Press; 1995:54-56. [Stoner G (Series Editor): Methods and Perspectives in Cell Biology, vall.] 
Book with institutiOl1aiauthor 
11. Advisory Commlttt!e on Genlltlc Modlncatlon: Annual Report. London; 1999. 
PhD thesis 
12. Kohavl R: Wrepparll for parrorlNlnca .nh.nc.ment end abllvlau. decl.lan gr.p". PhD thesis. Stanford University, Computllr 
5dence Department; 1995. 
Link/URL 
13.11-. MQUM Tumor Bialogy D ....... [http://tumor.informatics.jax.org/mtbwi/index.do] 
Micr080ft Word template 
Although we can aCO!pt manusaipts prepared as Microsoft: Word, RTF or PDF files, Wll have designed a Miaosoft: Word tllmplate that 
can be used to generate a standard style and format for your artide. It can bll used if you have not yet startlld to write your paper, 
or If It Is alrei!ldy wrttten and needs to be put Into Human Resources forHfJlJlth style. 
ppwnlpad the templgte (Mac and Windows compatible Word 1998/2000) from our site, and save it to your hard drive. Double click 
the terf1)late to open it. 
Hawta u •• the Hum.n Resources for Hu/th template 
The templl!lte consists of a standard set of hlladlngs that make up a Human ReSOutT:eS for Health Resel!lrch manusalpt,l!Ilong with 
dummy fragments of body text. Follow thesll steps to create your manuscript in the standard format: 
Replaice thll dummy text for TItle, Author detl!llls, Institutlonl!lll!lmlll!ltions, I!Ind the other sllctlons of the manuscrtpt with your 
own tt:xt (elthllr by llntertng the text dlrt!ctly or by aJttlng and pasting from your own manuscrtpt dOaJment). 
If there art! sections which you do not nelld, dlliete thllm (but check the rest of the Instructions for Authors to see whim 
sllctions are compulsory) . 
• If you need an additional CXlPY of a heading (e.g. for additional figure legends) just copy and pastll. 
• For the references, you ml!lY either manul!llly enter the references using the reterenr,e ,tyle given, or use bibliographic 
sottwl!lre to Insert them l!IutomatlaJlly. We provide style nles for ~ Reterenr,e Manager I!Ind ZSltm.. 
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Forextra convenience, you can use the template as one of your standard Word templates. To do this, put a copy of the template file 
in Word's 'Templates' folder, normally C:\program Files\Miatlsort Ofl'ia!!\Templates on a PC. The next time you cre<lte a new 
dowment in Word using the File menu, the template will appear as one of the available choices for a new document. 
return to top 
Preparing illustrations and figures 
Figures should be provided as separate "Ies lind should not be Induded In the main text of the submitted manuscript. Each "gure 
shoukl mmpr1sl!! only II single nle. There Is no charge for the use of color. 
Please read our figure preparation guidernes for detailed instructions on maximising the quality of your figures . 
Fonna .. 
The following file fonnats can be aa:epted: 
• I!PS (preferred fonnet fordlagniHTls) 
• PDF (also I!!spedally suitable for diagrams) 
PNG (preferred format for photos or images) 
Microsoft Word (figures must be a single page) 




• COX (ChemOraw) 
TGF (ISIS/Draw) 
Figure legends 
The legends should be included in the main manuscript text file ratherthan being a part of the figure file. For each figure, the 
following information should be provided: Figure number (in sequence, using Arabic numerals - i.e. Figure 1,2,3 etc); short title of 
figure (maxirTIJm lS words); detailed legend, up to 300 words. 
Pi .... noIII ttI.t It 1_ ....... pon .. bliity of .... lIIhor(_) tD obmln perml_lon from ... copyrtllht hold.r to reproduce t1gures or 
tables that have previously been published elsewhere. 
raturn to top 
Preparing a personal cover page 
If you wish to do so, you rTIIIIY submit lin IrTllllge which, In the event of publication, will be used to crellte a cover pllge for the PDF 
version of your IIrtk:le. The cover pllge will 11150 dlsplllY the joumallogo, !lrtlcle title lind cltlltlon detells. The Image ITIIIIY either be II 
ngure from your manusatpt or another relevant IrTllllge. You must have permission from the CXlpyrlght hokler to reproduce the IrTIIIIge. 
Images that do not meet our requirements will not be used. 
Images must be 300dpi and 155rrm square (1831 x 1831 pixels for a raster image). 
Allowable formats - EPS, PDF (for line drawings), PNG, TIFF (for photographs and screen dumps), JPEG, BMP, DOC, PPT, COX, TGF 
(ISIS/Draw). 
return to top 
Preparing tables 
Each table should be nurmered In sequence using Arabic numel'1llls (I.e. Table 1,2,3 etc.). TBbles should also h!lve a title thllt 
summarizes the whole table, maximum lS words. Detailed legends may then follow, but should be concise. 
Smaller tables considered to be Integl'1lll to the manuscr1pt can be pasted Into the document text file. These will be typeset and 
displayed In the "nal published form of the artk:le. Such tables should be formatted using the Table object' In a word processing 
program to ensure that columns of data are kept aligned when the "Ie Is sent electronically for review; this will not alw!lYS be the 
case If columns are generated by simply using tabs to separate text. Commas should not be used to Indlcete numer1cel values. Color 
and shading should not be used. 
Larger data sets cen be uploaded separately as additional files. Additional "Ies will not be displayed In the final, published form of the 
article, but a link will be provided to the "les as supplied by the author. 
TBbuillr data provided as additional "Ies cen be uploaded as an Excel spreadsheet (.xis) or comrTIIII sep!lrated wlues (.csv). As with 
all files, please use the standard file extenSions. 
return to top 
Preparing additional files 
Although Human Resources tbr Health does not restrict the length and quantity of data in a paper, there may still be occasions where 
an author wishes to provide data sets, tables, movie files, or other information as additional information. These files can be 
uploaded using the 'Additional Material "Ies' button In the manusalpt submission process. 
The mulmum "Ie size for additional nles Is 20 MB each, and nles will be vlrus-5canned on submission. 
Any additional files will be linked into the final published artide in the form supplied by the author, but will not be displayed within 
the paper. They will be made available In exactly the same form as originally provided. 
Ifedditionalmaterizll is provided, please list the following information in a separate section of the manusaipt text, at the end of the 
dowment text file: 
• File name 
• File format (Including name and a URL of an appropriate viewer II' format Is unusual) 
• lltle of data 
Description of data 
Additional datafiles should be referenced explidtly by file name within the body ofthe artide, e.g. 'See additional file 1: Movie1 for 
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the original data used to perl'ann this analysis', 
Fonn.a end uploading 
Ideally, nle formats for IIddltlonal files should not be pkltrann-speclnc, and should be vlewllble using free or widely aVllllable tools. 
The following are examples of suitable fonnats. 
Additional documentation 
• PDF (Adobe Acrobat) 
Animations 
• SWF (Shockwave Flash) 
• Movies 
• MOV (Qulck11me) 
• MPG (MPEG) 
• Tabular data 
• XLS (Excel spreadsheet) 
• CSV (Comma separated values) 
As with figure files, files should be given the standard nle extensions. This Is espedally Important for Macintosh users, since the Mac 
OS does not enforce the use of standard extensions. Please also make sure that each additional file Is II single table, figure or movie 
(please do not upload linked worksheets or PDF files larger than one sheet). 
SIMII self-contained websltes can be sublTtied as additional files, In such a way that they will be browsable from within the full text 
HTML version of the article. In order to do this, please follow these instructions: 
1. Create ill folder containing ill starting file celled Index.html (or Index.htm) In the root 
2. Put all files necessillry for viewing the mlnl-webslte within the folder, or sub-folders 
3. Ensure that all links are relative (Ie "Images/plctureJpg" rather than "/lmages/plctureJpg" or 
"http://yourdomain.net/images/picture.jpg'' or "C:\,Dowments and Settings\Username\My Documents\mini-
website\images\picture.jpg") and no link is longer than 255 dlaracters 
4. Acx:ess the index.html file iIInd browse around the mini-website, to ensure that the most commonly used browsers (Internet 
Explorerand Firefox) are able to view all parts of the mini-website without problems, it is ideal to check this on a difl'erent 
machine 
5. CO"1)ress the folder into a ZIP, check the file Size is under 20 MB, ensure that index.html is in the root of the ZIP, and that the 
file has .zlp extension, then submit as an iIIddltlonal file with yourartlde 
Style and language 
General 
return to top 
Currently, Human Resources for Health cen only accept manusa1pts wrttten In English. Spelling should be US English or British English, 
but not a mixture. 
Gene names should be in italic, but protein produc:±s should be in plain type. 
There Is no explk:lt limit on the length of artldes submitted, but authors are encouraged to be concise. There Is no restriction on the 
number of figures, tables or additional flies that can be Induded with each artlde online. Figures and tables should be sequentially 
referenced. Authors should Indude all relevant supporting data with eilldl artlde. 
Human Resources for Health will not edit submitted manusaipts for style or language; reviewers may advise rejection of a manuscript 
if it is compromised by grammatical errors. Authors are advised to write clearly and simply, and to have their article checked by 
colleagues before submission. In-house copyedltlng will be minimal. Non-native speakers of English may choose to make use of a 
copyedltlng service. 
Help and advice on adentif'1C writing 
The abstl'1lct Is one of the most Important Pillrts of a manusalpt. For guidance, please visit our pillge on "Wrftlng tltl,s and abstracts 
for sdentWc artlcl,s" 
Tim Albert has produced for BioMed Centl'1ll a list aftips for writing a scientific manuscript. MedBioWorid also provides a list of 
resources for science writing. 
Abbreviations 
Abbreviations should be used as sparingly as possible. They can be defined when first used or a list of abbreviations can be 
provided preceding the acknowledgements and references. 
• Please use double line spadng. 
Type the text unJustified, without hyphenating words at line breaks. 
Use hard returns only to end headings and paRlgraphs, not to rearrange lines. 
Capitalize only the!! first word, and prope!!r nouns, in the!! title. 
All page!!s should be!! numbe!!red. 
• USe!! the Human Resources for Health reference fonnat. 
• footnotes to text should not be used. 
• Greek and other spedal chillracters may be Induded.lfyou are unable to reproduce a partlwlar special character, please type 
out the name of the symbol In full. 
PI ... enllUre th.t .11 .peeI.1 c"r-=t.fII UMd.re embedded In the tIIxt" otherwl .. they will be Dt during connrslon to 
PDF. 
Genes, mutations, genotypes, and alleles should be indicated in italics, and authors are required to use!! approved gene 
symbols, names, and formatting. Promin products should be in plain type. 
Una 
51 Units should be used throughout (liter and molar are pel'l'litted, however). 
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